Anna Orlova

Preclinical Evaluation of a ¹⁷⁷Lu-Labeled Gastrin-Releasing Peptide Receptor Antagonist and Prostate Cancer Treatment with Monotherapy and in Combination with Everolimus

Kumar, Naveen; Bilinska, Adrianna; Menéndez, Elena; Läppchen, Tilman et al.

Ingår i ACS Pharmacology & Translational Science, s. 59-68, 2026

• DOI för Preclinical Evaluation of a ¹⁷⁷Lu-Labeled Gastrin-Releasing Peptide Receptor Antagonist and Prostate Cancer Treatment with Monotherapy and in Combination with Everolimus
• Ladda ner fulltext (pdf) av Preclinical Evaluation of a ¹⁷⁷Lu-Labeled Gastrin-Releasing Peptide Receptor Antagonist and Prostate Cancer Treatment with Monotherapy and in Combination with Everolimus

Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model

Tolmachev, Vladimir; Herlina, Amelinda Janice; Papalanis, Eleftherios; Bezverkhniaia, Ekaterina A. et al.

Ingår i International Journal of Molecular Sciences, 2026

• DOI för Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model
• Ladda ner fulltext (pdf) av Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model

Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging

Obeid, Karim; Bezverkhniaia, Ekaterina; Tolmachev, Vladimir M.; Orlova, Anna et al.

Ingår i EJNMMI Radiopharmacy and Chemistry, 2026

• DOI för Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging
• Ladda ner fulltext (pdf) av Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging

Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents

Rinne, Sara S.; Yin, Wen; Li, Ruonan; Ding, Haozhong et al.

Ingår i ACS Pharmacology & Translational Science, s. 3872-3885, 2025

• DOI för Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents
• Ladda ner fulltext (pdf) av Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents

Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68

Tolmachev, Vladimir M.; Bezverkhniaia, Ekaterina; Papalanis, Eleftherios; Muhammad, Abdullah Mujahid Bin et al.

Ingår i ACS Pharmacology & Translational Science, s. 3509-3522, 2025

• DOI för Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68
• Ladda ner fulltext (pdf) av Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68

Preclinical Evaluation of a ¹⁷⁷Lu-Labeled Gastrin-Releasing Peptide Receptor Antagonist and Prostate Cancer Treatment with Monotherapy and in Combination with Everolimus

Kumar, Naveen; Bilinska, Adrianna; Menéndez, Elena; Läppchen, Tilman et al.

Ingår i ACS Pharmacology & Translational Science, s. 59-68, 2026

• DOI för Preclinical Evaluation of a ¹⁷⁷Lu-Labeled Gastrin-Releasing Peptide Receptor Antagonist and Prostate Cancer Treatment with Monotherapy and in Combination with Everolimus
• Ladda ner fulltext (pdf) av Preclinical Evaluation of a ¹⁷⁷Lu-Labeled Gastrin-Releasing Peptide Receptor Antagonist and Prostate Cancer Treatment with Monotherapy and in Combination with Everolimus

Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model

Tolmachev, Vladimir; Herlina, Amelinda Janice; Papalanis, Eleftherios; Bezverkhniaia, Ekaterina A. et al.

Ingår i International Journal of Molecular Sciences, 2026

• DOI för Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model
• Ladda ner fulltext (pdf) av Efficient ⁶⁸Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model

Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging

Obeid, Karim; Bezverkhniaia, Ekaterina; Tolmachev, Vladimir M.; Orlova, Anna et al.

Ingår i EJNMMI Radiopharmacy and Chemistry, 2026

• DOI för Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging
• Ladda ner fulltext (pdf) av Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging

Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents

Rinne, Sara S.; Yin, Wen; Li, Ruonan; Ding, Haozhong et al.

Ingår i ACS Pharmacology & Translational Science, s. 3872-3885, 2025

• DOI för Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents
• Ladda ner fulltext (pdf) av Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents

Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68

Tolmachev, Vladimir M.; Bezverkhniaia, Ekaterina; Papalanis, Eleftherios; Muhammad, Abdullah Mujahid Bin et al.

Ingår i ACS Pharmacology & Translational Science, s. 3509-3522, 2025

• DOI för Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68
• Ladda ner fulltext (pdf) av Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68

Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.

Obeid, Karim; Bezverkhniaia, Ekaterina; Tolmachev, Vladimir M.; Orlova, Anna et al.

Ingår i EJNMMI Radiopharmacy and Chemistry, 2025

• DOI för Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.
• Ladda ner fulltext (pdf) av Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.

Linker modifications in radiolabeled RM26-based antagonists to gastrin-releasing peptide receptor (GRPR) improved tracers' pharmacokinetics

Bezverkhniaia, Ekaterina; Abouzayed, Ayman; Kanellopoulos, Panagiotis; Tolmachev, Vladimir M. et al.

Ingår i European Journal of Pharmaceutical Sciences, 2025

• DOI för Linker modifications in radiolabeled RM26-based antagonists to gastrin-releasing peptide receptor (GRPR) improved tracers' pharmacokinetics
• Ladda ner fulltext (pdf) av Linker modifications in radiolabeled RM26-based antagonists to gastrin-releasing peptide receptor (GRPR) improved tracers' pharmacokinetics

Phase I Clinical Study with the GRPR-Antagonist [^99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?

Orlova, Anna; Rybina, Anastasia; Medvedeva, Anna; Zelchan, Roman et al.

Ingår i Pharmaceutics, 2025

• DOI för Phase I Clinical Study with the GRPR-Antagonist [^99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?
• Ladda ner fulltext (pdf) av Phase I Clinical Study with the GRPR-Antagonist [^99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?

Reduction of negative charge in mercaptoacetyl-based chelators influences the biodistribution of prostate-specific membrane antigen-targeting pseudopeptides labeled with technetium-99m

Bezverkhniaia, Ekaterina; Kanellopoulos, Panagiotis; Rosenström, Ulrika; Tolmachev, Vladimir M. et al.

Ingår i ACS Pharmacology & Translational Science, s. 3600-3612, 2025

• DOI för Reduction of negative charge in mercaptoacetyl-based chelators influences the biodistribution of prostate-specific membrane antigen-targeting pseudopeptides labeled with technetium-99m
• Ladda ner fulltext (pdf) av Reduction of negative charge in mercaptoacetyl-based chelators influences the biodistribution of prostate-specific membrane antigen-targeting pseudopeptides labeled with technetium-99m

The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8

Bragina, Olga; Chernov, Vladimir; Larkina, Mariia; Varvashenya, Ruslan et al.

Ingår i Pharmaceutics, 2025

• DOI för The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8
• Ladda ner fulltext (pdf) av The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8

Designed Ankyrin Repeat Protein-Mediated Peptide Nucleic Acid-Based Pretargeting: A Proof-of-Principle Study

Oroujeni, Maryam; Westerlund, Kristina; Papalanis, Eleftherios; van Deventer, Alexander et al.

Ingår i Journal of Nuclear Medicine, s. 1105-1111, 2025

• DOI för Designed Ankyrin Repeat Protein-Mediated Peptide Nucleic Acid-Based Pretargeting: A Proof-of-Principle Study

A preclinical study on the influence of linkers in [⁶⁸Ga]Ga-NOTA-X-RM26 radiotracers for PET imaging of GRPR expression

Olaniran Håkansson, Esther; Zelepukin, Ivan V.; Obeid, Karim; Bitzios, Athanasios et al.

Ingår i EJNMMI Research, 2025

• DOI för A preclinical study on the influence of linkers in [⁶⁸Ga]Ga-NOTA-X-RM26 radiotracers for PET imaging of GRPR expression
• Ladda ner fulltext (pdf) av A preclinical study on the influence of linkers in [⁶⁸Ga]Ga-NOTA-X-RM26 radiotracers for PET imaging of GRPR expression

RM2 and DB15 analogues bearing [¹⁷⁷Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study

Kanellopoulos, Panagiotis; Bitzios, Athanasios; Zelepukin, Ivan; Bezverkhniaia, Ekaterina et al.

Ingår i EJNMMI Radiopharmacy and Chemistry, 2025

• DOI för RM2 and DB15 analogues bearing [¹⁷⁷Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study
• Ladda ner fulltext (pdf) av RM2 and DB15 analogues bearing [¹⁷⁷Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study

Single-Photon Emission Computer Tomography Imaging of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Cancer Patients Using a Novel Peptide-Based Probe [^99mTc]Tc-BQ0413 with Picomolar Affinity to PSMA: A Phase I/II Clinical Study

Medvedeva, Anna; Chernov, Vladimir; Larkina, Maria; Rybina, Anastasiya et al.

Ingår i ACS Pharmacology & Translational Science, s. 736-747, 2025

• DOI för Single-Photon Emission Computer Tomography Imaging of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Cancer Patients Using a Novel Peptide-Based Probe [^99mTc]Tc-BQ0413 with Picomolar Affinity to PSMA: A Phase I/II Clinical Study
• Ladda ner fulltext (pdf) av Single-Photon Emission Computer Tomography Imaging of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Cancer Patients Using a Novel Peptide-Based Probe [^99mTc]Tc-BQ0413 with Picomolar Affinity to PSMA: A Phase I/II Clinical Study

Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules

Tolmachev, Vladimir M.; Papalanis, Eleftherios; Bezverkhniaia, Ekaterina A.; Rosly, Alia Hani et al.

Ingår i ACS Pharmacology & Translational Science, s. 706-717, 2025

• DOI för Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules
• Ladda ner fulltext (pdf) av Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules

Synthesis and preclinical evaluation of gastrin releasing peptide receptor antagonist [¹⁸F]MeTz-PEG2-RM26 for positron emission tomography

Kanellopoulos, Panagiotis; Lundmark, Fanny; Abouzayed, Ayman; Balestri, Lorenzo Jacopo Ilic et al.

Ingår i EJNMMI Radiopharmacy and Chemistry, 2025

• DOI för Synthesis and preclinical evaluation of gastrin releasing peptide receptor antagonist [¹⁸F]MeTz-PEG2-RM26 for positron emission tomography
• Ladda ner fulltext (pdf) av Synthesis and preclinical evaluation of gastrin releasing peptide receptor antagonist [¹⁸F]MeTz-PEG2-RM26 for positron emission tomography

First-in-human experience with GRPR antagonist [⁶⁸Ga]Ga-NOTA-PEG₂-RM26 in prostate and breast cancer patients using PET/CT

Bjareback, Annie; Jonmarker, Olof; Tzortzakakis, Antonios; Jussing, Emma et al.

Ingår i EJNMMI Research, 2025

• DOI för First-in-human experience with GRPR antagonist [⁶⁸Ga]Ga-NOTA-PEG₂-RM26 in prostate and breast cancer patients using PET/CT
• Ladda ner fulltext (pdf) av First-in-human experience with GRPR antagonist [⁶⁸Ga]Ga-NOTA-PEG₂-RM26 in prostate and breast cancer patients using PET/CT

Evaluation of maSSS/maSES-PEG2-RM26 for their potential therapeutic use after labeling with Re-188. Could their [^99mTc]Tc-labeled counterparts be used to estimate dosimetry?

Kanellopoulos, Panagiotis; Yu, Quanyi; Abouzayed, Abouzayed; Bezverkhniaia, Ekaterina et al.

Ingår i EJNMMI Radiopharmacy and Chemistry, 2025

• DOI för Evaluation of maSSS/maSES-PEG2-RM26 for their potential therapeutic use after labeling with Re-188. Could their [^99mTc]Tc-labeled counterparts be used to estimate dosimetry?
• Ladda ner fulltext (pdf) av Evaluation of maSSS/maSES-PEG2-RM26 for their potential therapeutic use after labeling with Re-188. Could their [^99mTc]Tc-labeled counterparts be used to estimate dosimetry?

Evaluation of a novel ¹⁷⁷Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile

Liu, Yongsheng; Oroujeni, Maryam; Liao, Yunqi; Vorobyeva, Anzhelika et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 4038-4048, 2024

• DOI för Evaluation of a novel ¹⁷⁷Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile
• Ladda ner fulltext (pdf) av Evaluation of a novel ¹⁷⁷Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile

Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation

Oroujeni, Maryam; Carlqvist, Matilda; Ryer, Eva; Orlova, Anna et al.

Ingår i EJNMMI Radiopharmacy and Chemistry, 2024

• DOI för Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation
• Ladda ner fulltext (pdf) av Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation

Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation.

Zhang, Jie; Bodenko, Vitalina; Larkina, Maria; Bezverkhniaia, Ekaterina et al.

Ingår i Journal of Controlled Release, s. 468-478, 2024

• DOI för Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation.
• Ladda ner fulltext (pdf) av Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation.

Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts

Zhang, Jie; Rinne, Sara S.; Yin, Wen; Leitao, Charles Dahlsson et al.

Ingår i ACS Pharmacology & Translational Science, s. 3228-3240, 2024

• DOI för Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts
• Ladda ner fulltext (pdf) av Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts

Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer: A preclinical study of the theranostic pair [⁵⁵Co]Co- and [¹⁷⁷Lu]Lu-DOTA-RM26

Baun, Christina; Olsen, Birgitte Brinkmann; Alves, Carla Maria Lourenco; Ditzel, Henrik Jorn et al.

Ingår i Nuclear Medicine and Biology, 2024

• DOI för Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer: A preclinical study of the theranostic pair [⁵⁵Co]Co- and [¹⁷⁷Lu]Lu-DOTA-RM26

Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting

Westerlund, Kristina; Oroujeni, Maryam; Gestin, Maxime; Clinton, Jacob et al.

Ingår i ACS Pharmacology & Translational Science, s. 1595-1611, 2024

• DOI för Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting
• Ladda ner fulltext (pdf) av Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting

Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug Delivery

Nagy, Abel; Abouzayed, Ayman; Kanellopoulos, Panagiotis; Landmark, Fredrika et al.

Ingår i ACS Omega, s. 36122-36133, 2024

• DOI för Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug Delivery
• Ladda ner fulltext (pdf) av Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug Delivery

Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [^99mTc]Tc(CO)₃-(HE)₃-Ec1 for Visualization of EpCAM-Expressing Lung Cancer

Zelchan, Roman; Chernov, Vladimir; Medvedeva, Anna; Rybina, Anastasia et al.

Ingår i Cancers, 2024

• DOI för Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [^99mTc]Tc(CO)₃-(HE)₃-Ec1 for Visualization of EpCAM-Expressing Lung Cancer
• Ladda ner fulltext (pdf) av Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [^99mTc]Tc(CO)₃-(HE)₃-Ec1 for Visualization of EpCAM-Expressing Lung Cancer

GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics

Obeid, Karim; Kanellopoulos, Panagiotis; Abouzayed, Ayman; Mattsson, Adam et al.

Ingår i Pharmaceutics, 2024

• DOI för GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics
• Ladda ner fulltext (pdf) av GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics

Synthesis and Preclinical Evaluation of Urea-Based Prostate-Specific Membrane Antigen-Targeted Conjugates Labeled with ¹⁷⁷Lu

Machulkin, Aleksei E.; Petrov, Stanislav A.; Bodenko, Vitalina; Larkina, Mariia S. et al.

Ingår i ACS Pharmacology & Translational Science, s. 1457-1473, 2024

• DOI för Synthesis and Preclinical Evaluation of Urea-Based Prostate-Specific Membrane Antigen-Targeted Conjugates Labeled with ¹⁷⁷Lu

Two Novel [⁶⁸Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar¹¹]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate Cancer

Kanellopoulos, Panagiotis; Bezverkhniaia, Ekaterina; Abouzayed, Ayman; Rosenström, Ulrika et al.

Ingår i ACS Omega, s. 18608-18616, 2024

• DOI för Two Novel [⁶⁸Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar¹¹]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate Cancer
• Ladda ner fulltext (pdf) av Two Novel [⁶⁸Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar¹¹]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate Cancer

Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion

Deyev, Sergey M.; Oroujeni, Maryam; Garousi, Javad; Graeslund, Torbjoern et al.

Ingår i International Journal of Molecular Sciences, 2024

• DOI för Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion
• Ladda ner fulltext (pdf) av Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion

Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m

Bezverkhniaia, Ekaterina; Kanellopoulos, Panagiotis; Rosenström, Ulrika; Tolmachev, Vladimir et al.

Ingår i International Journal of Molecular Sciences, 2024

• DOI för Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m
• Ladda ner fulltext (pdf) av Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m

Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the ^99mTc-Based Imaging of HER2-Expressing Malignant Tumors

Larkina, Maria; Varvashenya, Ruslan; Yuldasheva, Feruza; Plotnikov, Evgenii et al.

Ingår i Molecular Pharmaceutics, s. 1919-1932, 2024

• DOI för Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the ^99mTc-Based Imaging of HER2-Expressing Malignant Tumors

Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology

Kanellopoulos, Panagiotis; Mattsson, Adam; Abouzayed, Ayman; Obeid, Karim et al.

Ingår i EJNMMI Radiopharmacy and Chemistry, 2024

• DOI för Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology
• Ladda ner fulltext (pdf) av Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology

Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with Tc-99m and I-125

Tolmachev, Vladimir; Bodenko, Vitalina; Orlova, Anna; Schulga, Alexey et al.

Ingår i Oncology Letters, 2023

• DOI för Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with Tc-99m and I-125
• Ladda ner fulltext (pdf) av Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with Tc-99m and I-125

Radionuclide Therapy of HER2-Expressing Xenografts Using [Lu-177]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab

Liu, Yongsheng; Xu, Tianqi; Vorobyeva, Anzhelika; Loftenius, Annika et al.

Ingår i Cancers, 2023

• DOI för Radionuclide Therapy of HER2-Expressing Xenografts Using [Lu-177]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab
• Ladda ner fulltext (pdf) av Radionuclide Therapy of HER2-Expressing Xenografts Using [Lu-177]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab

Comparison of HER2-targeted affibody conjugates loaded with auristatin-and maytansine-derived drugs

Yin, Wen; Xu, Tianqi; Ding, Haozhong; Zhang, Jie et al.

Ingår i Journal of Controlled Release, s. 515-527, 2023

• DOI för Comparison of HER2-targeted affibody conjugates loaded with auristatin-and maytansine-derived drugs

Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity

Leitao, Charles Dahlsson; Borras, Anna Mestre; Xu, Tianqi; Oroujeni, Maryam et al.

Ingår i Journal of Controlled Release, s. 185-195, 2023

• DOI för Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity

Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3

Oroujeni, Maryam; Bezverkhniaia, Ekaterina A.; Xu, Tianqi; Liu, Yongsheng et al.

Ingår i Nuclear Medicine and Biology, 2023

• DOI för Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
• Ladda ner fulltext (pdf) av Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3

Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics

Abouzayed, Ayman; Kanellopoulos, Panagiotis; Gorislav, Alisa; Tolmachev, Vladimir et al.

Ingår i Biomolecules, 2023

• DOI för Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics
• Ladda ner fulltext (pdf) av Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics

Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation

Lundmark, Fanny; Abouzayed, Ayman; Rinne, Sara S.; Timofeev, Vasiliy et al.

Ingår i Cancers, 2023

• DOI för Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation
• Ladda ner fulltext (pdf) av Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation

Phase I clinical evaluation of ^99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer

Bragina, Olga; Chernov, Vladimir; Larkina, Mariia; Rybina, Anstasiya et al.

Ingår i Theranostics, s. 4858-4871, 2023

• DOI för Phase I clinical evaluation of ^99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer
• Ladda ner fulltext (pdf) av Phase I clinical evaluation of ^99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer

¹⁷⁷Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry

Abouzayed, Ayman; Seitova, Kamila; Lundmark, Fanny; Bodenko, Vitalina et al.

Ingår i Frontiers in Oncology, 2023

• DOI för ¹⁷⁷Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
• Ladda ner fulltext (pdf) av ¹⁷⁷Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry

Preclinical Evaluation of a Novel High-Affinity Radioligand [^99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)

Bezverkhniaia, Ekaterina; Kanellopoulos, Panagiotis; Abouzayed, Ayman; Larkina, Mariia et al.

Ingår i International Journal of Molecular Sciences, 2023

• DOI för Preclinical Evaluation of a Novel High-Affinity Radioligand [^99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)
• Ladda ner fulltext (pdf) av Preclinical Evaluation of a Novel High-Affinity Radioligand [^99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)

Synthesis, I-123-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures

Hasnowo, Lutfi A.; Larkina, Maria S.; Plotnikov, Evgenii; Bodenko, Vitalina et al.

Ingår i International Journal of Molecular Sciences, 2023

• DOI för Synthesis, I-123-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures
• Ladda ner fulltext (pdf) av Synthesis, I-123-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures

The GRPR Antagonist [^99mTc]Tc-maSSS-PEG₂-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity

Abouzayed, Ayman; Borin, Jesper; Lundmark, Fanny; Rybina, Anastasiya et al.

Ingår i Diagnostics, 2023

• DOI för The GRPR Antagonist [^99mTc]Tc-maSSS-PEG₂-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity
• Ladda ner fulltext (pdf) av The GRPR Antagonist [^99mTc]Tc-maSSS-PEG₂-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity

Phase I Trial of [Tc-99m]Tc-maSSS-PEG(2)-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors

Chernov, Vladimir; Rybina, Anastasiya; Zelchan, Roman; Medvedeva, Anna et al.

Ingår i Cancers, 2023

• DOI för Phase I Trial of [Tc-99m]Tc-maSSS-PEG(2)-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors
• Ladda ner fulltext (pdf) av Phase I Trial of [Tc-99m]Tc-maSSS-PEG(2)-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors

Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model

Xu, Tianqi; Schulga, Alexey; Konovalova, Elena; Rinne, Sara S. et al.

Ingår i International Journal of Molecular Sciences, 2023

• DOI för Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model
• Ladda ner fulltext (pdf) av Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model

Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis

Liu, Yongsheng; Gueler, Rezan; Liao, Yunqi; Vorobyeva, Anzhelika et al.

Ingår i Pharmaceutics, 2022

• DOI för Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis
• Ladda ner fulltext (pdf) av Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis

Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule ¹⁸⁸Re-ZHER2:41071

Liu, Yongsheng; Vorobyeva, Anzhelika; Orlova, Anna; Konijnenberg, Mark W. et al.

Ingår i Pharmaceutics, 2022

• DOI för Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule ¹⁸⁸Re-ZHER2:41071
• Ladda ner fulltext (pdf) av Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule ¹⁸⁸Re-ZHER2:41071

Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3

Oroujeni, Maryam; Bezverkhniaia, Ekaterina A.; Xu, Tianqi; Liu, Yongsheng et al.

Ingår i Pharmaceutics, 2022

• DOI för Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
• Ladda ner fulltext (pdf) av Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3

Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2

Xu, Tianqi; Zhang, Jie; Oroujeni, Maryam; Tretyakova, Maria S. et al.

Ingår i Pharmaceutics, 2022

• DOI för Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2
• Ladda ner fulltext (pdf) av Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2

Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT

Liu, Yongsheng; Yu, Shengze; Xu, Tianqi; Bodenko, Vitalina et al.

Ingår i Pharmaceutics, 2022

• DOI för Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
• Ladda ner fulltext (pdf) av Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT

Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands

Lundmark, Fanny; Olanders, Gustav; Rinne, Sara Sophie; Abouzayed, Ayman et al.

Ingår i Pharmaceutics, 2022

• DOI för Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands
• Ladda ner fulltext (pdf) av Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands

Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules

Rinne, Sara S.; Yin, Wen; Borras, Anna Mestre; Abouzayed, Ayman et al.

Ingår i Biomedicines, 2022

• DOI för Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules
• Ladda ner fulltext (pdf) av Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules

Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart

Garousi, Javad; Xu, Tianqi; Liu, Yongsheng; Vorontsova, Olga et al.

Ingår i Pharmaceutics, 2022

• DOI för Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart
• Ladda ner fulltext (pdf) av Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart

Direct In Vivo Comparison of ^99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy

Tolmachev, Vladimir; Bodenko, Vitalina; Oroujeni, Maryam; Deyev, Sergey et al.

Ingår i International Journal of Molecular Sciences, 2022

• DOI för Direct In Vivo Comparison of ^99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy
• Ladda ner fulltext (pdf) av Direct In Vivo Comparison of ^99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy

Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing Xenografts

Oroujeni, Maryam; Tano, Hanna; Vorobyeva, Anzhelika; Liu, Yongsheng et al.

Ingår i Journal of Nuclear Medicine, s. 1046-1051, 2022

• DOI för Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing Xenografts

Phase I Trial of ^99mTc-(HE)₃-G3, a DARPin-Based Probe for Imaging of HER2 Expression in Breast Cancer

Bragina, Olga; Chernov, Vladimir; Schulga, Alexey; Konovalova, Elena et al.

Ingår i Journal of Nuclear Medicine, s. 528-535, 2022

• DOI för Phase I Trial of ^99mTc-(HE)₃-G3, a DARPin-Based Probe for Imaging of HER2 Expression in Breast Cancer

Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody^® Molecules ¹⁷⁷Lu-ABY-271 and ¹⁷⁷Lu-ABY-027: Impact of DOTA Position on ABD Domain

Liu, Yongsheng; Vorobyeva, Anzhelika; Xu, Tianqi; Orlova, Anna et al.

Ingår i Pharmaceutics, 2021

• DOI för Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody^® Molecules ¹⁷⁷Lu-ABY-271 and ¹⁷⁷Lu-ABY-027: Impact of DOTA Position on ABD Domain
• Ladda ner fulltext (pdf) av Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody^® Molecules ¹⁷⁷Lu-ABY-271 and ¹⁷⁷Lu-ABY-027: Impact of DOTA Position on ABD Domain

A method of drug delivery to tumors based on rapidly biodegradable drug-loaded containers

Parakhonskiy, Bogdan; Shilyagina, Natalia Yu; Gusliakova, Olga; Volovetskiy, Artur B. et al.

Ingår i Applied Materials Today, 2021

• DOI för A method of drug delivery to tumors based on rapidly biodegradable drug-loaded containers

Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein

Garousi, Javad; Ding, Haozhong; von Witting, Emma; Xu, Tianqi et al.

Ingår i Pharmaceutics, 2021

• DOI för Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein
• Ladda ner fulltext (pdf) av Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein

Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model

Xu, Tianqi; Ding, Haozhong; Vorobyeva, Anzhelika; Oroujeni, Maryam et al.

Ingår i Cancers, 2021

• DOI för Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model
• Ladda ner fulltext (pdf) av Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model

Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle

Garousi, Javad; von Witting, Emma; Borin, Jesper; Vorobyeva, Anzhelika et al.

Ingår i Biomaterials, 2021

• DOI för Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle
• Ladda ner fulltext (pdf) av Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle

Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution

Ding, Haozhong; Xu, Tianqi; Zhang, Jie; Tolmachev, Vladimir et al.

Ingår i Pharmaceutics, 2021

• DOI för Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution
• Ladda ner fulltext (pdf) av Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution

The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy

Yin, Wen; Xu, Tianqi; Altai, Mohamed; Oroujeni, Maryam et al.

Ingår i Pharmaceutics, 2021

• DOI för The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy
• Ladda ner fulltext (pdf) av The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy

Preclinical Evaluation of ^99mTc-Labeled GRPR Antagonists maSSS/SES-PEG₂-RM26 for Imaging of Prostate Cancer

Abouzayed, Ayman; Rinne, Sara S.; Sabahnoo, Hamideh; Sörensen, Jens et al.

Ingår i Pharmaceutics, 2021

• DOI för Preclinical Evaluation of ^99mTc-Labeled GRPR Antagonists maSSS/SES-PEG₂-RM26 for Imaging of Prostate Cancer
• Ladda ner fulltext (pdf) av Preclinical Evaluation of ^99mTc-Labeled GRPR Antagonists maSSS/SES-PEG₂-RM26 for Imaging of Prostate Cancer

The Use of a Non-Conventional Long-Lived Gallium Radioisotope ⁶⁶Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR: 2377 Affibody Molecule

Oroujeni, Maryam; Xu, Tianqi; Gagnon, Katherine; Rinne, Sara S. et al.

Ingår i Pharmaceutics, 2021

• DOI för The Use of a Non-Conventional Long-Lived Gallium Radioisotope ⁶⁶Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR: 2377 Affibody Molecule
• Ladda ner fulltext (pdf) av The Use of a Non-Conventional Long-Lived Gallium Radioisotope ⁶⁶Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR: 2377 Affibody Molecule

Comparative Evaluation of Novel Lu-177-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting

Tano, Hanna; Oroujeni, Maryam; Vorobyeva, Anzhelika; Westerlund, Kristina et al.

Ingår i Cancers, 2021

• DOI för Comparative Evaluation of Novel Lu-177-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting
• Ladda ner fulltext (pdf) av Comparative Evaluation of Novel Lu-177-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting

Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model

Xu, Tianqi; Vorobyeva, Anzhelika; Schulga, Alexey; Konovalova, Elena et al.

Ingår i Cancers, 2021

• DOI för Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
• Ladda ner fulltext (pdf) av Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model

Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1

Deyev, Sergey M.; Xu, Tianqi; Liu, Yongsheng; Schulga, Alexey et al.

Ingår i Cancers, 2021

• DOI för Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
• Ladda ner fulltext (pdf) av Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1

Ga-66-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [Ga-66]Ga-NOTA-PEG(2)-RM26

Rinne, Sara S.; Abouzayed, Ayman; Gagnon, Katherine; Tolmachev, Vladimir et al.

Ingår i Scientific Reports, 2021

• DOI för Ga-66-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [Ga-66]Ga-NOTA-PEG(2)-RM26
• Ladda ner fulltext (pdf) av Ga-66-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [Ga-66]Ga-NOTA-PEG(2)-RM26

HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers

Rinne, Sara S.; Dahlsson Leitao, Charles; Abouzayed, Ayman; Vorobyeva, Anzhelika et al.

Ingår i Cancers, s. 4791-4791, 2021

• DOI för HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers
• Ladda ner fulltext (pdf) av HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers

Preclinical Evaluation of Tc-99m-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake

Oroujeni, Maryam; Rinne, Sara S.; Vorobyeva, Anzhelika; Loftenius, Annika et al.

Ingår i International Journal of Molecular Sciences, 2021

• DOI för Preclinical Evaluation of Tc-99m-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
• Ladda ner fulltext (pdf) av Preclinical Evaluation of Tc-99m-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake

Phase I study of ^99mTc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer

Bragina, Olga; von Witting, Emma; Garousi, Javad; Zelchan, Roman et al.

Ingår i Journal of Nuclear Medicine, s. 493-499, 2021

• DOI för Phase I study of ^99mTc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer

Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use

Bragina, O. D.; Chernov, V. I.; Garbukov, E. Yu; Doroshenko, A. V. et al.

Ingår i Bûlleten' sibirskoj mediciny, s. 23-30, 2021

• DOI för Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use
• Ladda ner fulltext 1 (pdf) av Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use
• Ladda ner fulltext 2 (pdf) av Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use

In vitro and in vivo evaluation of the radiochemical compound based on 99mtechnetium labelled DARPin9_29 for molecular visualization of malignancies overexpressing Her2/neu

Bragina, O. D.; Vorobyeva, Anzhelika; Tolmachev, Vladimir M.; Orlova, Anna et al.

Ingår i Medical Radiology and Radiation Safety, s. 37-41, 2020

• DOI för In vitro and in vivo evaluation of the radiochemical compound based on 99mtechnetium labelled DARPin9_29 for molecular visualization of malignancies overexpressing Her2/neu

Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules

Rinne, Sara S.; Xu, Tianqi; Leitao, Charles Dahlsson; Stahl, Stefan et al.

Ingår i International Journal of Molecular Sciences, 2020

• DOI för Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules
• Ladda ner fulltext (pdf) av Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules

Increasing thermal stability and improving biodistribution of VEGFR2-binding affibody molecules by a combination of in silico and directed evolution approaches

Güler, Rezan; Svedmark, Siri Flemming; Abouzayed, Ayman; Orlova, Anna et al.

Ingår i Scientific Reports, 2020

• DOI för Increasing thermal stability and improving biodistribution of VEGFR2-binding affibody molecules by a combination of in silico and directed evolution approaches
• Ladda ner fulltext (pdf) av Increasing thermal stability and improving biodistribution of VEGFR2-binding affibody molecules by a combination of in silico and directed evolution approaches

HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution

Ding, Haozhong; Altai, Mohamed; Yin, Wen; Lindbo, Sarah et al.

Ingår i Pharmaceutics, 2020

• DOI för HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution
• Ladda ner fulltext (pdf) av HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution

Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer

Abouzayed, Ayman; Tano, Hanna; Nagy, Abel; Rinne, Sara S. et al.

Ingår i Pharmaceutics, 2020

• DOI för Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
• Ladda ner fulltext (pdf) av Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer

Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model

Lundmark, Fanny; Abouzayed, Ayman; Mitran, Bogdan; Rinne, Sara S. et al.

Ingår i Pharmaceutics, 2020

• DOI för Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
• Ladda ner fulltext (pdf) av Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model

Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model.

Leitao, Charles Dahlsson; Rinne, Sara S.; Altai, Mohamed; Vorontsova, Olga et al.

Ingår i Pharmaceutics, 2020

• DOI för Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model.
• Ladda ner fulltext (pdf) av Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model.

Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1

Vorobyeva, Anzhelika; Bezverkhniaia, Ekaterina; Konovalova, Elena; Schulga, Alexey et al.

Ingår i Molecules, 2020

• DOI för Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
• Ladda ner fulltext (pdf) av Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1

Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer

Baun, Christina; Mitran, Bogdan; Rinne, Sara S.; Dam, Johan H. et al.

Ingår i Molecules, 2020

• DOI för Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer
• Ladda ner fulltext (pdf) av Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer

Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting

Myrhammar, Anders; Vorobyeva, Anzhelika; Westerlund, Kristina; Yoneoka, Shuichiro et al.

Ingår i Scientific Reports, 2020

• DOI för Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting
• Ladda ner fulltext (pdf) av Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting

Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond.

Garousi, Javad; Orlova, Anna; Frejd, Fredrik Y.; Tolmachev, Vladimir

Ingår i EJNMMI Radiopharmacy and Chemistry, 2020

• DOI för Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond.

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1

Vorobyeva, Anzhelika; Konovalova, Elena; Xu, Tianqi; Schulga, Alexey et al.

Ingår i International Journal of Molecular Sciences, 2020

• DOI för Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
• Ladda ner fulltext (pdf) av Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1

Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules

Rinne, Sara S.; Leitao, Charles Dahlsson; Saleh-nihad, Zahra; Mitran, Bogdan et al.

Ingår i International Journal of Molecular Sciences, 2020

• DOI för Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules
• Ladda ner fulltext (pdf) av Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules

Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1

Deyev, Sergey M.; Vorobyeva, Anzhelika; Schulga, Alexey; Abouzayed, Ayman et al.

Ingår i International Journal of Biological Macromolecules, s. 216-225, 2020

• DOI för Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1
• Ladda ner fulltext (pdf) av Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1

Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of ⁶⁸Ga-Labeled Tracers

Dahlsson Leitao, Charles; Rinne, Sara S.; Mitran, Bogdan; Vorobyeva, Anzhelika et al.

Ingår i International Journal of Molecular Sciences, 2019

• DOI för Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of ⁶⁸Ga-Labeled Tracers
• Ladda ner fulltext (pdf) av Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of ⁶⁸Ga-Labeled Tracers

Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug Conjugates

Ding, Haozhong; Altai, Mohamed; Rinne, Sara S.; Vorobyeva, Anzhelika et al.

Ingår i Cancers, 2019

• DOI för Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug Conjugates
• Ladda ner fulltext (pdf) av Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug Conjugates

Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111

Rinne, Sara S.; Leitao, Charles Dahlsson; Mitran, Bogdan; Bass, Tarek Z. et al.

Ingår i Scientific Reports, 2019

• DOI för Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111
• Ladda ner fulltext (pdf) av Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111

Potent and specific fusion toxins consisting of a HER2-binding, ABD-derived affinity protein, fused to truncated versions of Pseudomonas exotoxin A

Liu, Hao; Lindbo, Sarah; Ding, Haozhong; Altai, Mohamed et al.

Ingår i International Journal of Oncology, s. 309-319, 2019

• DOI för Potent and specific fusion toxins consisting of a HER2-binding, ABD-derived affinity protein, fused to truncated versions of Pseudomonas exotoxin A

Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart

Oroujeni, Maryam; Abouzayed, Ayman; Lundmark, Fanny; Mitran, Bogdan et al.

Ingår i Pharmaceutics, 2019

• DOI för Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart
• Ladda ner fulltext (pdf) av Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart

Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer

Abouzayed, Ayman; Yim, Cheng-Bin; Mitran, Bogdan; Rinne, Sara S. et al.

Ingår i Pharmaceutics, 2019

• DOI för Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer
• Ladda ner fulltext (pdf) av Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer

Increase in negative charge of ⁶⁸Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules

Rinne, Sara S.; Leitao, Charles Dahlsson; Gentry, Joshua; Mitran, Bogdan et al.

Ingår i Scientific Reports, 2019

• DOI för Increase in negative charge of ⁶⁸Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules
• Ladda ner fulltext (pdf) av Increase in negative charge of ⁶⁸Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules

Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26

Mitran, Bogdan; Thisgaard, Helge; Rinne, Sara S.; Dam, Johan Hygum et al.

Ingår i Scientific Reports, 2019

• DOI för Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26
• Ladda ner fulltext (pdf) av Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26

Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake

Rosestedt, Maria; Andersson, Ken G.; Rinne, Sara S.; Leitao, Charles Dahlsson et al.

Ingår i Scientific Reports, 2019

• DOI för Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake
• Ladda ner fulltext (pdf) av Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake

Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts

Garousi, Javad; Huizing, Fokko J.; Vorobyeva, Anzhelika; Mitran, Bogdan et al.

Ingår i Scientific Reports, 2019

• DOI för Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts
• Ladda ner fulltext (pdf) av Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts

Optimal composition and position of histidine-containing tags improves biodistribution of Tc-99m-labeled DARP in G3

Vorobyeva, Anzhelika; Schulga, Alexey; Konovalova, Elena; Guler, Rezan et al.

Ingår i Scientific Reports, 2019

• DOI för Optimal composition and position of histidine-containing tags improves biodistribution of Tc-99m-labeled DARP in G3
• Ladda ner fulltext (pdf) av Optimal composition and position of histidine-containing tags improves biodistribution of Tc-99m-labeled DARP in G3

Indirect Radioiodination of DARPin G3 Using N-succinimidyl-Para-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging

Vorobyeva, Anzhelika; Schulga, Alexey; Rinne, Sara S.; Günther, Tyran et al.

Ingår i International Journal of Molecular Sciences, 2019

• DOI för Indirect Radioiodination of DARPin G3 Using N-succinimidyl-Para-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging
• Ladda ner fulltext (pdf) av Indirect Radioiodination of DARPin G3 Using N-succinimidyl-Para-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging

Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2

Vorobyeva, Anzhelika; Schulga, Alexey; Konovalova, Elena; Güler, Rezan et al.

Ingår i International Journal of Oncology, s. 1209-1220, 2019

• DOI för Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2
• Ladda ner fulltext (pdf) av Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2

Bispecific GRPR-antagonistic anti-PSMA/GRPR heterodimer for PET and SPECT diagnostic imaging of prostate cancer

Mitran, Bogdan; Varasteh, Zohreh; Abouzayed, Ayman; Rinne, Sara S. et al.

Ingår i Cancers, 2019

• DOI för Bispecific GRPR-antagonistic anti-PSMA/GRPR heterodimer for PET and SPECT diagnostic imaging of prostate cancer
• Ladda ner fulltext (pdf) av Bispecific GRPR-antagonistic anti-PSMA/GRPR heterodimer for PET and SPECT diagnostic imaging of prostate cancer

Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26

Mitran, Bogdan; Rinne, Sara S.; Konijnenberg, Mark W.; Maina, Theodosia et al.

Ingår i International Journal of Cancer, s. 3347-3358, 2019

• DOI för Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26
• Ladda ner fulltext (pdf) av Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26

Selection of the optimal macrocyclic chelators for labeling with ¹¹¹In and ⁶⁸Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6

von Witting, Emma; Garousi, Javad; Lindbo, Sarah; Vorobyeva, Anzhelika et al.

Ingår i European journal of pharmaceutics and biopharmaceutics, s. 109-120, 2019

• DOI för Selection of the optimal macrocyclic chelators for labeling with ¹¹¹In and ⁶⁸Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6
• Ladda ner fulltext (pdf) av Selection of the optimal macrocyclic chelators for labeling with ¹¹¹In and ⁶⁸Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6

Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting

Westerlund, Kristina; Vorobyeva, Anzhelika; Mitran, Bogdan; Orlova, Anna et al.

Ingår i Biomaterials, s. 73-85, 2019

• DOI för Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting
• Ladda ner fulltext (pdf) av Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting

Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties

Deyev, Sergey; Vorobyeva, Anzhelika; Schulga, Alexey; Proshkina, Galina et al.

Ingår i Molecular Pharmaceutics, s. 995-1008, 2019

• DOI för Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties

Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours

Garousi, Javad; Lindbo, Sarah; Borin, Jesper; von Witting, Emma et al.

Ingår i European journal of pharmaceutics and biopharmaceutics, s. 37-48, 2019

• DOI för Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours
• Ladda ner fulltext (pdf) av Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours

Affibody-mediated imaging of EGFR expression in prostate cancer using radiocobalt-labeled DOTA-Z(EGFR:2377)

Mitran, Bogdan; Andersson, Ken Gosta; Lindström, Elin; Garousi, Javad et al.

Ingår i Oncology Reports, s. 534-542, 2019

• DOI för Affibody-mediated imaging of EGFR expression in prostate cancer using radiocobalt-labeled DOTA-Z(EGFR:2377)

Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors

Vorobyeva, Anzhelika; Bragina, Olga; Altai, Mohamed; Mitran, Bogdan et al.

Ingår i Contrast Media & Molecular Imaging, s. 1-11, 2018

• DOI för Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors
• Ladda ner fulltext (pdf) av Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors

Evaluation of the Therapeutic Potential of a HER3-Binding Affibody Construct TAM-HER3 in Comparison with a Monoclonal Antibody, Seribantumab

Orlova, Anna; Bass, Tarek Z.; Rinne, Sara S.; Leitao, Charles Dahlsson et al.

Ingår i Molecular Pharmaceutics, s. 3394-3403, 2018

• DOI för Evaluation of the Therapeutic Potential of a HER3-Binding Affibody Construct TAM-HER3 in Comparison with a Monoclonal Antibody, Seribantumab

Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs

Altai, Mohamed; Leitao, Charles Dahlsson; Rinne, Sara S.; Vorobyeva, Anzhelika et al.

Ingår i Cells, 2018

• DOI för Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
• Ladda ner fulltext (pdf) av Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs

Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors

Altai, Mohamed; Liu, Hao; Ding, Haozhong; Mitran, Bogdan et al.

Ingår i Journal of Controlled Release, s. 84-95, 2018

• DOI för Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors

Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model

Mitran, Bogdan; Güler, Rezan; Roche, Francis P.; Lindström, Elin et al.

Ingår i Theranostics, s. 4462-4476, 2018

• DOI för Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model
• Ladda ner fulltext (pdf) av Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model

Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe

Honarvar, Hadis; Calce, Enrica; Doti, Nunzianna; Langella, Emma et al.

Ingår i Scientific Reports, 2018

• DOI för Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe
• Ladda ner fulltext (pdf) av Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe

Molecular design of radiocopper-labelled Affibody molecules

Tolmachev, Vladimir; Grönroos, Tove J; Yim, Cheng-Bin; Garousi, Javad et al.

Ingår i Scientific Reports, 2018

• DOI för Molecular design of radiocopper-labelled Affibody molecules
• Ladda ner fulltext (pdf) av Molecular design of radiocopper-labelled Affibody molecules

Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy

Vorobyeva, Anzhelika; Westerlund, Kristina; Mitran, Bogdan; Altai, Mohamed et al.

Ingår i Scientific Reports, 2018

• DOI för Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy
• Ladda ner fulltext (pdf) av Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy

PP15 89Zr-Siderophore-Affibody conjugates for imaging EGFR expression

Summer, D; Garousi, Javad; Oroujeni, Maryam; Mitran, Bogdan et al.

Ingår i EJNMMI Research, 2018

• DOI för PP15 89Zr-Siderophore-Affibody conjugates for imaging EGFR expression

Influence of composition of cysteine-containing peptide-based chelators on biodistribution of ^99mTc-labeled anti-EGFR affibody molecules

Oroujeni, Maryam; Andersson, Ken G.; Steinhardt, Xenia; Altai, Mohamed et al.

Ingår i Amino Acids, s. 981-994, 2018

• DOI för Influence of composition of cysteine-containing peptide-based chelators on biodistribution of ^99mTc-labeled anti-EGFR affibody molecules
• Ladda ner fulltext (pdf) av Influence of composition of cysteine-containing peptide-based chelators on biodistribution of ^99mTc-labeled anti-EGFR affibody molecules

Cyclic versus Noncyclic Chelating Scaffold for Zr-89-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression

Summer, Dominik; Garousi, Javad; Oroujeni, Maryam; Mitran, Bogdan et al.

Ingår i Molecular Pharmaceutics, s. 175-185, 2018

• DOI för Cyclic versus Noncyclic Chelating Scaffold for Zr-89-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression
• Ladda ner fulltext (pdf) av Cyclic versus Noncyclic Chelating Scaffold for Zr-89-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression

Preclinical Evaluation of [Ga-68]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors

Oroujeni, Maryam; Garousi, Javad; Andersson, Ken G.; Lofblom, John et al.

Ingår i CELLS, 2018

• DOI för Preclinical Evaluation of [Ga-68]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors
• Ladda ner fulltext (pdf) av Preclinical Evaluation of [Ga-68]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors

Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle

Westerlund, Kristina; Altai, Mohamed; Mitran, Bogdan; Konijnenberg, Mark et al.

Ingår i Journal of Nuclear Medicine, s. 1092-1098, 2018

• DOI för Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle

Selection of the most optimal ADAPT6-based probe for imaging of HER2 using PET and SPECT

Garousi, Javad; Lindbo, S.; Mitran, Bogdan; Vorobyeva, Anzhelika et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

Optimized Molecular Design of ADAPT-Based HER2-Imaging Probes Labeled with ¹¹¹In and ⁶⁸Ga

Lindbo, Sarah; Garousi, Javad; Mitran, Bogdan; Vorobyeva, Anzhelika et al.

Ingår i Molecular Pharmaceutics, s. 2674-2683, 2018

• DOI för Optimized Molecular Design of ADAPT-Based HER2-Imaging Probes Labeled with ¹¹¹In and ⁶⁸Ga

Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Molecular Imaging of HER2 Expression in Cancer Using SPECT

Vorobyeva, Anzhelika; Bragina, O.; Altai, Mohamed; Mitran, Bogdan et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI för Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Molecular Imaging of HER2 Expression in Cancer Using SPECT

Development of a PET Imaging Approach for Selection of Patients for Affibody-Based PNA-Mediated Pretargeted Radionuclide Therapy

Vorobyeva, Anzhelika; Westerlund, K.; Mitran, Bogdan; Altai, Mohamed et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI för Development of a PET Imaging Approach for Selection of Patients for Affibody-Based PNA-Mediated Pretargeted Radionuclide Therapy

Comparative evaluation of anti-EFGR affibody molecules labelled with gallium-68 and zirconium-89 using desferrioxamine B as a chelator

Oroujeni, Maryam; Garousi, Javad; Andersson, K.; Löfblom, J. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI för Comparative evaluation of anti-EFGR affibody molecules labelled with gallium-68 and zirconium-89 using desferrioxamine B as a chelator

Imaging contrast of HER3 expression using monomeric affibody-based imaging probe can be improved by co-injection of affibody trimer

Orlova, Anna; Rosestedt, Maria; Rinne, Sara S.; Mitran, Bogdan et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI för Imaging contrast of HER3 expression using monomeric affibody-based imaging probe can be improved by co-injection of affibody trimer

Optimization of molecular design of Ga-68-labeled affibody molecule for PET imaging of HER3 expression

Rinne, Sara S.; Mitran, Bogdan; Vorobyeva, Anzhelika; Leitao, C. Dahlsson et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI för Optimization of molecular design of Ga-68-labeled affibody molecule for PET imaging of HER3 expression

Selection of optimal macrocyclic chelator for high contrast PET imaging of gastrin releasing peptide receptor using cobalt-labeled bombesin antagonist RM26

Mitran, Bogdan; Thisgaard, H.; Rinne, Sara S.; Rosenström, Ulrika et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

GRPR-targeted radiotherapy using the Lu-177-labeled GRPR-antagonist DOTAGA-PEG(2)-RM26

Mitran, Bogdan; Rinne, Sara S.; Azamy, F.; Vorobyeva, Anzhelika et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

Same-day imaging using small proteins: Clinical experience and translational prospects in oncology.

Krasniqi, Ahmet; D'Huyvetter, Matthias; Devoogdt, Nick; Frejd, Fredrik Y. et al.

Ingår i Journal of Nuclear Medicine, s. 885-891, 2018

• DOI för Same-day imaging using small proteins: Clinical experience and translational prospects in oncology.

Radionuclide tumor targeting using ADAPT scaffold proteins: aspects of label positioning and residualizing properties of the label

Lindbo, Sarah; Garousi, Javad; Mitran, Bogdan; Buijs, Jos et al.

Ingår i Journal of Nuclear Medicine, s. 93-99, 2018

• DOI för Radionuclide tumor targeting using ADAPT scaffold proteins: aspects of label positioning and residualizing properties of the label

Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m

Garousi, Javad; Lindbo, Sarah; Mitran, Bogdan; Buijs, Jos et al.

Ingår i Scientific Reports, 2017

• DOI för Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m
• Ladda ner fulltext (pdf) av Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m

The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule

Garousi, Javad; Andersson, Ken G.; Dam, Johan H.; Olsen, Birgitte B. et al.

Ingår i Scientific Reports, 2017

• DOI för The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule
• Ladda ner fulltext (pdf) av The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule

In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin- binding therapeutic affibody construct

Bass, Tarek Z.; Rosestedt, Maria; Mitran, Bogdan; Frejd, Fredrik Y. et al.

Ingår i Scientific Reports, 2017

• DOI för In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin- binding therapeutic affibody construct
• Ladda ner fulltext (pdf) av In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin- binding therapeutic affibody construct

Evaluation of radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression

Rosestedt, Maria; Andersson, Ken G; Mitran, Bogdan; Rinne, Sara S. et al.

Ingår i International Journal of Oncology, s. 1765-1774, 2017

• DOI för Evaluation of radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression
• Ladda ner fulltext (pdf) av Evaluation of radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression

High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26

Mitran, Bogdan; Thisgaard, Helge; Rosenström, Ulrika; Dam, Johan Hygum et al.

Ingår i Contrast Media & Molecular Imaging, 2017

• DOI för High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26
• Ladda ner fulltext (pdf) av High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26

Novel high affinity affibody for radionuclide imaging of VEGFR2 in glioma vasculature: proof-of-principle in murine model

Mitran, Bogdan; Guler, R.; Roche, Francis P.; Lindström, Elin et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

Radiocobalt-labeled anti-HER1 affibody molecule DOTA-Z(EGFR:2377) for imaging of low HER1 expression in prostate cancer pre-clinical model

Mitran, Bogdan; Garousi, Javad; Rosestedt, Maria; Lindström, Elin et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

GRPR-Targeted Radiotherapy: Influence of Chelator on Labeling and Biodistribution of Four Lu-177-Labeled Analogues of the GRPR-Antagonist PEG2-RM26

Orlova, Anna; Mitran, Bogdan; Maina, T.; Nock, B. A. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

Influence of composition of cysteine-containing peptide based chelators on biodistribution of Tc-99m-labelled anti-EGFR affibody molecules

Oroujeni, Maryam; Anderson, K. G.; Garousi, Javad; Altai, Mohamed et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

Optimal molecular design of radiocopper-labelled affibody molecules

Tolmachev, Vladimir; Yim, C.; Garousi, Javad; Yue, Y. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

Optimization of affibody molecule for imaging of HER3 expression: negatively charged metal-chelator complex increases imaging contrast

Rinne, Sara S.; Mitran, Bogdan; Leitao, C. Dahlsson; Ståhl, S. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with Cu-64 Using NOTA and NODAGA

Tolmachev, Vladimir; Yim, Cheng-Bin; Rajander, Johan; Perols, Anna et al.

Ingår i Contrast Media & Molecular Imaging, s. 1-12, 2017

• DOI för Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with Cu-64 Using NOTA and NODAGA
• Ladda ner fulltext (pdf) av Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with Cu-64 Using NOTA and NODAGA

Synthesis of C-11-labeled Sulfonyl Carbamates through a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols, and [C-11]CO

Stevens, Marc; Chow, Shiao; Estrada, Sergio; Eriksson, Jonas et al.

Ingår i ChemistryOpen, s. 566-573, 2016

• DOI för Synthesis of C-11-labeled Sulfonyl Carbamates through a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols, and [C-11]CO
• Ladda ner fulltext (pdf) av Synthesis of C-11-labeled Sulfonyl Carbamates through a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols, and [C-11]CO

Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors

Honarvar, Hadis; Westerlund, Kristina; Altai, Mohamed; Sandström, Mattias et al.

Ingår i Theranostics, s. 93-103, 2016

• DOI för Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors
• Ladda ner fulltext (pdf) av Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [(68)Ga]ABY-025 Affibody PET/CT

Sörensen, Jens; Velikyan, Irina; Sandberg, Dan; Wennborg, Anders et al.

Ingår i Theranostics, s. 262-271, 2016

• DOI för Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [(68)Ga]ABY-025 Affibody PET/CT
• Ladda ner fulltext (pdf) av Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [(68)Ga]ABY-025 Affibody PET/CT

Synthesis of ¹¹C-labelled Sulfonyl Carbamates via a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols and [¹¹C]CO

Stevens, Marc; Chow, Chow; Estrada, Sergio; Eriksson, Jonas et al.

Ingår i ChemistryOpen, s. 566-573, 2016

• DOI för Synthesis of ¹¹C-labelled Sulfonyl Carbamates via a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols and [¹¹C]CO
• Ladda ner fulltext (pdf) av Synthesis of ¹¹C-labelled Sulfonyl Carbamates via a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols and [¹¹C]CO

Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.

Mitran, Bogdan; Varasteh, Zohreh; Selvaraju, Ram Kumar; Lindeberg, Gunnar et al.

Ingår i International journal of oncology, s. 2124-2134, 2016

• DOI för Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.

Comparative evaluation of Affibody molecules for radionuclide imaging of in vivo expression of carbonic anhydrase IX

Garousi, Javad; Honarvar, Hadis; Andersson, Ken G.; Mitran, Bogdan et al.

Ingår i Molecular Pharmaceutics, s. 3676-3687, 2016

• DOI för Comparative evaluation of Affibody molecules for radionuclide imaging of in vivo expression of carbonic anhydrase IX

Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules

Westerlund, Kristina; Honarvar, Hadis; Norrström, Emily; Strand, Joanna et al.

Ingår i Molecular Pharmaceutics, s. 1668-1678, 2016

• DOI för Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules

Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR: 2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator

Andersson, Ken G.; Oroujeni, Maryam; Garousi, Javad; Mitran, Bogdan et al.

Ingår i International journal of oncology, s. 2285-2293, 2016

• DOI för Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR: 2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator
• Ladda ner fulltext (pdf) av Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR: 2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator

Influence of molecular design on biodistribution and targeting properties of an Affibody-fused HER2-recognising anticancer toxin

Altai, Mohamed; Liu, Hao; Orlova, Anna; Tolmachev, Vladimir et al.

Ingår i International Journal of Oncology, s. 1185-1194, 2016

• DOI för Influence of molecular design on biodistribution and targeting properties of an Affibody-fused HER2-recognising anticancer toxin

Feasibility of in vivo imaging of VEGFR2 expression using high affinity antagonistic biparatopic affibody construct Z(VEGFR2)-Bp(2)

Mitran, Bogdan; Guler, R.; Lindström, Eva; Fleetwood, F. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2016

Influence of Histidine-Containing Tags on the Biodistribution of ADAPT Scaffold Proteins.

Lindbo, Sarah; Garousi, Javad; Åstrand, Mikael; Honarvar, Hadis et al.

Ingår i Bioconjugate chemistry, s. 716-726, 2016

• DOI för Influence of Histidine-Containing Tags on the Biodistribution of ADAPT Scaffold Proteins.

Feasibility of affibody-based bioorthogonal chemistry-mediated radionuclide pretargeting

Altai, Mohamed; Perols, Anna; Tsourma, Maria; Mitran, Bogdan et al.

Ingår i Journal of Nuclear Medicine, s. 431-436, 2016

• DOI för Feasibility of affibody-based bioorthogonal chemistry-mediated radionuclide pretargeting

Comparative evaluation of Lu-177-HP2 and In-111-HP2, secondary agents for affibody-based PNA-mediated radionuclide pretargeting

Altai, Mohamed; Westerlund, K.; Velletta, J.; Honarvar, Hadis et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2016

Development and Evaluation of Radiocobalt-labelled Affibody Molecule for Next Day PET Imaging of HER3 Expression

Rosestedt, Maria; Mitran, Bogdan; Andersson, K. G.; Löfblom, J. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2016

Influence of the N-terminal amino acid sequence on imaging properties of In-111-labeled anti-HER2 scaffold protein ADAPT6

Garousi, Javad; Lindbo, S.; Honarvar, Hadis; Velletta, J. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2016

Evaluation of Affibody Molecules for Radionuclide Imaging of Carbonic Abhydrase IX Expression In Vivo

Garousi, Javad; Honarvar, Hadis; Andersson, K.; Mitran, Bogdan et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2016

Imaging of EGFR Expression Using 99mTC-Labelled ZEGFR:2377 Affibody Molecule

Oroujeni, Maryam; Andersson, K.; Garousi, Javad; Mitran, Bogdan et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2016

Improving of molecular design of a novel Affibody-fused HER2-recognising anticancer toxin using radionuclide-based techniques

Altai, Mohamed; Liu, H.; Orlova, Anna; Tolmachev, Vladimir et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2016

In vivo evaluation of pharmacokinetics, tumors targeting and therapeutic efficacy of a novel format of HER3-targeting affibody molecule with prolonged blood circulation

Orlova, Anna; Rosestedt, Maria; Mitran, Bogdan; Bass, T. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2016

Influence of the N-Terminal Composition on Targeting Properties of Radiometal-Labeled Anti-HER2 Scaffold Protein ADAPT6

Garousi, Javad; Lindbo, Sarah; Honarvar, Hadis; Velletta, Justin et al.

Ingår i Bioconjugate chemistry, s. 2678-2688, 2016

• DOI för Influence of the N-Terminal Composition on Targeting Properties of Radiometal-Labeled Anti-HER2 Scaffold Protein ADAPT6

Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule Ga-68-ABY-025 in Breast Cancer Patients

Sandström, Mattias; Lindskog, Karolina; Velikyan, Irma; Wennborg, Anders et al.

Ingår i Journal of Nuclear Medicine, s. 867-871, 2016

• DOI för Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule Ga-68-ABY-025 in Breast Cancer Patients

PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR: 2377 affibody molecules.

Garousi, Javad; Andersson, Ken G; Mitran, Bogdan; Pichl, Marie-Louise et al.

Ingår i International journal of oncology, s. 1325-1332, 2016

• DOI för PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR: 2377 affibody molecules.
• Ladda ner fulltext (pdf) av PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR: 2377 affibody molecules.

ADAPT, a novel scaffold protein-based probe for radionuclide imaging of molecular targets that are expressed in disseminated cancers

Garousi, Javad; Lindbo, Sarah; Nilvebrant, Johan; Åstrand, Mikael et al.

Ingår i Cancer Research, s. 4364-4371, 2015

• DOI för ADAPT, a novel scaffold protein-based probe for radionuclide imaging of molecular targets that are expressed in disseminated cancers

Affibody-mediated PET imaging of HER3 expression in malignant tumours

Rosestedt, Maria; Andersson, Ken G.; Mitran, Bogdan; Tolmachev, Vladimir et al.

Ingår i Scientific Reports, 2015

• DOI för Affibody-mediated PET imaging of HER3 expression in malignant tumours
• Ladda ner fulltext (pdf) av Affibody-mediated PET imaging of HER3 expression in malignant tumours

The use of radiocobalt as a label improves PET imaging of EGFR using DOTA-conjugated affibody molecules

Garousi, Javad; Anderson, K.; Dam, J. H.; Olsen, B. B. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2015

Development of radiocobalt-labeled GRPR antagonist NOTA-PEG2-RM26.

Mitran, Bogdan; Varasteh, Zohreh; Rosenström, Ulrika; Tolmachev, Vladimir et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2015

Influence of chelators on targeting properties of In-111 and Ga-68 labeled GRPR antagonist

Orlova, Anna; Varasteh, Zohreh; Mitran, Bogdan; Rosestedt, Maria et al.

Ingår i Journal of labelled compounds & radiopharmaceuticals, 2015

Comparing the measured affinity of 111In-labeled ligands for cellular receptors by monitoring gamma, beta, or x-ray radiation with three different LigandTracer® devices

Orlova, Anna; varasteh, Zohreh

Ingår i Journal of Radioanalytical and Nuclear Chemistry, s. 823-828, 2015

Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors

Andersson, Ken G.; Rosestedt, Maria; Varasteh, Zohreh; Malm, Magdalena et al.

Ingår i Oncology Reports, s. 1042-1048, 2015

• DOI för Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors
• Ladda ner fulltext (pdf) av Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors

Evaluation of (99m)Tc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression

Mitran, Bogdan; Altai, Mohamed; Hofström, Camilla; Honarvar, Hadis et al.

Ingår i Amino Acids, s. 303-15, 2015

• DOI för Evaluation of (99m)Tc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression
• Ladda ner fulltext (pdf) av Evaluation of (99m)Tc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression

The effect of macrocyclic chelators on the targeting properties of the ⁶⁸Ga-labeled gastrin releasing peptide receptor antagonist PEG₂-RM26

Varasteh, Zohreh; Mitran, Bogdan; Rosenström, Ulrika; Velikyan, Irina et al.

Ingår i Nuclear Medicine and Biology, s. 446-454, 2015

• DOI för The effect of macrocyclic chelators on the targeting properties of the ⁶⁸Ga-labeled gastrin releasing peptide receptor antagonist PEG₂-RM26

Imaging of HER2 may improve the outcome of external irradiation therapy for prostate cancer patients

Andersson, Jennie; Rosestedt, Maria; Orlova, Anna

Ingår i Oncology Letters, s. 950-954, 2015

• DOI för Imaging of HER2 may improve the outcome of external irradiation therapy for prostate cancer patients

Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity

Strand, Joanna; Nordeman, Patrik; Honarvar, Hadis; Altai, Mohamed et al.

Ingår i ChemistryOpen, s. 174-182, 2015

• DOI för Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity
• Ladda ner fulltext (pdf) av Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity

Comparing the measured affinity of (111) In-labeled ligands for cellular receptors by monitoring gamma, beta, or X-ray radiation with three different LigandTracer (R) devices

Varasteh, Zohreh; Orlova, Anna

Ingår i Journal of Radioanalytical and Nuclear Chemistry, s. 823-828, 2015

• DOI för Comparing the measured affinity of (111) In-labeled ligands for cellular receptors by monitoring gamma, beta, or X-ray radiation with three different LigandTracer (R) devices

Affibody-based bioorthogonal chemistry-mediated radionuclide pretargeting: proof-of-principle

Altai, Mohamed; Tsourma, M.; Mitran, Bogdan; Honarvar, Hadis et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2015

Feasibility of Affibody molecule-based PNA-mediated pretargeting

Honarvar, Hadis; Westerlund, K.; Altai, Mohamed; Sandstrom, Mattias et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2015

Influence of Histidine-Containing Tags on Biodistribution of Radiolabelled ADAPT-Based Imaging Probes

Lindbo, S.; Garousi, Javad; Astrand, M.; Honarvar, Hadis et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2015

Good manufacturing practice compliant production of a Ga-68-labelled Affibody agent for breast cancer imaging: first-in-human

Velikyan, Irina; Wennborg, Anders; Feldwisch, Joachim; Orlova, Anna et al.

Ingår i Journal of labelled compounds & radiopharmaceuticals, 2015

Position for Site-Specific Attachment of a DOTA Chelator to Synthetic Affibody Molecules Has a Different Influence on the Targeting Properties of 68Ga- Compared to 111In-Labeled Conjugates.

Honarvar, Hadis; Strand, Joanna; Perols, Anna; Orlova, Anna et al.

Ingår i Molecular Imaging, s. 1-12, 2014

• DOI för Position for Site-Specific Attachment of a DOTA Chelator to Synthetic Affibody Molecules Has a Different Influence on the Targeting Properties of 68Ga- Compared to 111In-Labeled Conjugates.

The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a Ga-68-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin

Varasteh, Zohreh; Rosenström, Ulrika; Velikyan, Irina; Mitran, Bogdan et al.

Ingår i Molecules, s. 10455-10472, 2014

• DOI för The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a Ga-68-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin
• Ladda ner fulltext (pdf) av The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a Ga-68-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin

GMP compliant preparation of a (68)Gallium-labeled Affibody analogue for breast cancer patient examination: first-in-man

Velikyan, Irina; Wennborg, A.; Feldwisch, J.; Orlova, Anna et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014

Histidine-Rich Glycoprotein Uptake and Turnover Is Mediated by Mononuclear Phagocytes.

Tugues, Sònia; Roche, Francis; Noguer, Oriol; Orlova, Anna et al.

Ingår i PLOS ONE, 2014

• DOI för Histidine-Rich Glycoprotein Uptake and Turnover Is Mediated by Mononuclear Phagocytes.
• Ladda ner fulltext (pdf) av Histidine-Rich Glycoprotein Uptake and Turnover Is Mediated by Mononuclear Phagocytes.

Development of ADAPT6 as a new scaffold protein for radionuclide molecular imaging

Garousi, Javad; Lindbo, S.; Orlova, Anna; Astrand, M. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014

111In-labeled NOTA-conjugated Affibody molecules for visualization of HER3 expression in malignant tumors

Andersson, K. G.; Varasteh, Zohreh; Rosestedt, Maria; Malm, M. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014

Development of a I-124-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution

Tolmachev, Vladimir; Malmberg, Jennie; Estrada, Sergio; Eriksson, Olof et al.

Ingår i International Journal of Oncology, s. 1998-2008, 2014

• DOI för Development of a I-124-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution
• Ladda ner fulltext (pdf) av Development of a I-124-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution

In Vitro Therapy Modeling of HER2 Targeting Therapy in Disseminated Prostate Cancer

Andersson, Jennie; Rosestedt, Maria; Asplund, Veronika; Yavari, Nazila et al.

Ingår i International Journal of Oncology, s. 2153-2158, 2014

• DOI för In Vitro Therapy Modeling of HER2 Targeting Therapy in Disseminated Prostate Cancer
• Ladda ner fulltext (pdf) av In Vitro Therapy Modeling of HER2 Targeting Therapy in Disseminated Prostate Cancer

Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer

Sandin, Linda; Orlova, Anna; Gustafsson, Erika; Ellmark, Peter et al.

Ingår i Cancer Immunology Research, s. 80-90, 2014

• DOI för Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer
• Ladda ner fulltext (pdf) av Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer

Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3 08699 affibody molecule

Orlova, Anna; Malm, Magdalena; Rosestedt, Maria; Varasteh, Zohreh et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 1450-1459, 2014

• DOI för Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3 08699 affibody molecule
• Ladda ner fulltext (pdf) av Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3 08699 affibody molecule

Incorporation of a Triglutamyl Spacer Improves the Biodistribution of Synthetic Affibody Molecules Radiofluorinated at the N-Terminus via Oxime Formation with (18)F-4-Fluorobenzaldehyde

Rosik, Daniel; Thibblin, Alf; Antoni, Gunnar; Honarvar, Hadis et al.

Ingår i Bioconjugate chemistry, s. 82-92, 2014

• DOI för Incorporation of a Triglutamyl Spacer Improves the Biodistribution of Synthetic Affibody Molecules Radiofluorinated at the N-Terminus via Oxime Formation with (18)F-4-Fluorobenzaldehyde
• Ladda ner fulltext (pdf) av Incorporation of a Triglutamyl Spacer Improves the Biodistribution of Synthetic Affibody Molecules Radiofluorinated at the N-Terminus via Oxime Formation with (18)F-4-Fluorobenzaldehyde

Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591

Tolmachev, Vladimir; Varasteh, Zohreh; Honarvar, Hadis; Hosseinimehr, Seyed Jalal et al.

Ingår i Journal of Nuclear Medicine, s. 294-300, 2014

• DOI för Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591
• Ladda ner fulltext (pdf) av Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591

¹⁸⁸Re-Z_HER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment

Altai, Mohamed; Wållberg, Helena; Honarvar, Hadis; Strand, Joanna et al.

Ingår i Journal of Nuclear Medicine, s. 1842-1848, 2014

• DOI för ¹⁸⁸Re-Z_HER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment
• Ladda ner fulltext (pdf) av ¹⁸⁸Re-Z_HER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment

Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine

Altai, Mohamed; Orlova, Anna; Tolmachev, Vladimir

Ingår i Current pharmaceutical design, s. 2275-2292, 2014

• DOI för Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine

Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with ¹⁸⁸Re

Altai, Mohamed; Honarvar, Hadis; Wållberg, Helena; Strand, Joanna et al.

Ingår i European Journal of Medicinal Chemistry, s. 519-528, 2014

• DOI för Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with ¹⁸⁸Re
• Ladda ner fulltext (pdf) av Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with ¹⁸⁸Re

Gallium-68-Labeled Affibody Molecule for PET Imaging of PDGFRβ Expression in Vivo

Strand, Joanna; Varasteh, Zohreh; Eriksson, Olof; Abrahmsen, Lars et al.

Ingår i Molecular Pharmaceutics, s. 3957-3964, 2014

• DOI för Gallium-68-Labeled Affibody Molecule for PET Imaging of PDGFRβ Expression in Vivo

PET Imaging of HER3-Expression in Tumours Using a 68Ga-Labeled Affibody Molecule

Rosestedt, Maria; Andersson, K.; Lofblom, J.; Mitran, Bogdan et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014

Influence of chelators on biodistribution and targeting properties of GRPR antagonist

Mitran, Bogdan; Varasteh, Zohreh; Rosestedt, Maria; Velikyan, Irina et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014

Gallium-68-labeled affibody molecule for PET imaging of PDGFR beta expression in vivo

Strand, Joanna; Varasteh, Zohreh; Eriksson, Olof; Abrahmsen, L. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014

Evaluation of 99mTc-ZIGF1R:4551-GGGC Affibody Molecule, a New Construct for Imaging the Insulin-like Growth Factor Type 1 Receptor Expression

Mitran, Bogdan; Altai, M.; Hofstrom, C.; Honarvar, Hadis et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014

[^99mTc(CO)₃]⁺-(HE)₃-Z_IGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours

Orlova, Anna; Hofström, Camilla; Strand, Joanna; Varasteh, Zohreh et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 439-449, 2013

• DOI för [^99mTc(CO)₃]⁺-(HE)₃-Z_IGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours
• Ladda ner fulltext (pdf) av [^99mTc(CO)₃]⁺-(HE)₃-Z_IGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours

Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

Malm, Magdalena; Kronqvist, Nina; Lindberg, Hanna; Gudmundsdotter, Lindvi et al.

Ingår i PLOS ONE, 2013

• DOI för Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
• Ladda ner fulltext (pdf) av Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

Influence of Macrocyclic Chelators on the Targeting Properties of ⁶⁸Ga-Labeled Synthetic Affibody Molecules: Comparison with ¹¹¹In-Labeled Counterparts

Strand, Joanna; Honarvar, Hadis; Perols, Anna; Orlova, Anna et al.

Ingår i PLOS ONE, 2013

• DOI för Influence of Macrocyclic Chelators on the Targeting Properties of ⁶⁸Ga-Labeled Synthetic Affibody Molecules: Comparison with ¹¹¹In-Labeled Counterparts
• Ladda ner fulltext (pdf) av Influence of Macrocyclic Chelators on the Targeting Properties of ⁶⁸Ga-Labeled Synthetic Affibody Molecules: Comparison with ¹¹¹In-Labeled Counterparts

In Vitro and In Vivo Evaluation of a F-18-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging

Varasteh, Zohreh; Åberg, Ola; Velikyan, Irina; Lindeberg, Gunnar et al.

Ingår i PLOS ONE, 2013

• DOI för In Vitro and In Vivo Evaluation of a F-18-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging
• Ladda ner fulltext (pdf) av In Vitro and In Vivo Evaluation of a F-18-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging

Detecting ligand interactions with G protein-coupled receptors in real-time on living cells

Xu, Bo; Varasteh, Zohreh; Orlova, Anna; Andersson, Karl et al.

Ingår i Biochemical and Biophysical Research Communications - BBRC, s. 820-824, 2013

• DOI för Detecting ligand interactions with G protein-coupled receptors in real-time on living cells
• Ladda ner fulltext (pdf) av Detecting ligand interactions with G protein-coupled receptors in real-time on living cells

Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein

Orlova, Anna; Jonsson, Andreas; Rosik, Daniel; Lundqvist, Hans et al.

Ingår i Journal of Nuclear Medicine, s. 961-968, 2013

• DOI för Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein
• Ladda ner fulltext (pdf) av Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein

HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [^99mTc(CO)₃]⁺-Labeled Affibody Molecules

Hofström, Camilla; Altai, Mohamed; Honarvar, Hadis; Strand, Joanna et al.

Ingår i Journal of Medicinal Chemistry, s. 4966-4974, 2013

• DOI för HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [^99mTc(CO)₃]⁺-Labeled Affibody Molecules
• Ladda ner fulltext (pdf) av HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [^99mTc(CO)₃]⁺-Labeled Affibody Molecules

Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with ⁶⁸Ga and ¹¹¹In via Maleimido Derivatives of DOTA and NODAGA

Altai, Mohamed; Strand, Joanna; Rosik, Daniel; Selvaraju, Ram Kumar et al.

Ingår i Bioconjugate chemistry, s. 1102-1109, 2013

• DOI för Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with ⁶⁸Ga and ¹¹¹In via Maleimido Derivatives of DOTA and NODAGA
• Ladda ner fulltext (pdf) av Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with ⁶⁸Ga and ¹¹¹In via Maleimido Derivatives of DOTA and NODAGA

GRPR antagonist NOTA-P2-RM26 labeled with fluorine-18: radiochemistry, in vitro and in vivo evaluation

Varasteh, Zohreh; Åberg, Ola; Lindberg, G.; Antoni, Gunnar et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2013

Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for In Vivo molecular imaging

Honarvar, Hadis; Jokilaakso, Nima; Andersson, Karl; Malmberg, Jennie et al.

Ingår i Nuclear Medicine and Biology, s. 378-386, 2013

• DOI för Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for In Vivo molecular imaging
• Ladda ner fulltext (pdf) av Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for In Vivo molecular imaging

In Vivo and In Vitro Studies on Renal Uptake of Radiolabeled Affibody Molecules for Imaging of HER2 Expression in Tumors

Altai, Mohamed; Varasteh, Zohreh; Andersson, Karl; Eek, Annemarie et al.

Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 187-195, 2013

• DOI för In Vivo and In Vitro Studies on Renal Uptake of Radiolabeled Affibody Molecules for Imaging of HER2 Expression in Tumors
• Ladda ner fulltext (pdf) av In Vivo and In Vitro Studies on Renal Uptake of Radiolabeled Affibody Molecules for Imaging of HER2 Expression in Tumors

In vivo imaging of PDGFR beta expression using In-111-DOTA-Z09591 Affibody molecule

Tolmachev, Vladimir; Varasteh, Zohreh; Honarvar, Hadis; Eriksson, Olof et al.

Ingår i Journal of labelled compounds & radiopharmaceuticals, 2013

Feasibility of radionuclide imaging of HER3-expressing tumors using affibody molecules

Orlova, Anna; Malm, Magdalena; Lindberg, Hanna; Varasteh, Zohreh et al.

Ingår i Journal of labelled compounds & radiopharmaceuticals, 2013

(AlF)-F-18-labelling of NOTA-P2-RM26 and its evaluation as a PET ligand for GRPR/BB2

Åberg, Ola; Varasteh, Zohreh; Lindeberg, Gunnar; Larhed, Mats et al.

Ingår i Journal of labelled compounds & radiopharmaceuticals, 2013

Synthesis and Characterization of a High-Affinity NOTA-Conjugated Bombesin Antagonist for GRPR-Targeted Tumor Imaging

Varasteh, Zohreh; Velikyan, Irina; Lindeberg, Gunnar; Sörensen, Jens et al.

Ingår i Bioconjugate chemistry, s. 1144-1153, 2013

• DOI för Synthesis and Characterization of a High-Affinity NOTA-Conjugated Bombesin Antagonist for GRPR-Targeted Tumor Imaging
• Ladda ner fulltext (pdf) av Synthesis and Characterization of a High-Affinity NOTA-Conjugated Bombesin Antagonist for GRPR-Targeted Tumor Imaging

Selection of an optimal cysteine-containing peptide-based chelator for labeling of Affibody molecules with 188-Re

Altai, Mohamed; Honarvar, Hadis; Wållberg, Helena; Strand, Joanna et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2013

• DOI för Selection of an optimal cysteine-containing peptide-based chelator for labeling of Affibody molecules with 188-Re

Feasibility of radionuclide imaging of HER3-expressing tumours using technetium-99m labeled affibody molecules

Orlova, Anna; Malm, M.; Lindberg, H.; Varasteh, Zohreh et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2013

Influence of macrocyclic chelators on biodistribution and targeting properties of 68Ga-labeled synthetic Affibody molecules. Comparison with 111In-labeled counterparts

Strand, Joanna; Honarvar, Hadis; Perols, A.; Orlova, Anna et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2013

HAHAHA-, HIHIHI-. HKHKHK. HHHHHH- and HEHEHE- tags: Influence of position and composition of histidine-containing tags on biodistribution of [99mTc(CO) 3]+- labeled affibody molecules

Tolmachev, Vladimir; Hofstrom, C.; Altai, Mohamed; Honarvar, Hadis et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2013

Imaging of PDGFRbeta expression in vivo using Affibody molecule In-111-DOTA-Z09591

Tolmachev, Vladimir; Varasteh, Zohreh; Honarvar, Hadis; Hosseinimehr, S. Jalal et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2013

Increase of HER2 expression in prostate cancer cell lines as reaction on external irradiation

Malmberg, Jennie; Rosestedt, Maria; Orlova, Anna

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2013

Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts.

Malmberg, Jennie; Perols, Anna; Varasteh, Zohreh; Altai, Mohamed et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 481-492, 2012

• DOI för Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts.

Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with ¹¹¹In using a maleimido derivative of NODAGA

Altai, Mohamed; Perols, Anna; Eriksson Karlström, Amelie; Sandström, Mattias et al.

Ingår i Nuclear Medicine and Biology, s. 518-529, 2012

• DOI för Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with ¹¹¹In using a maleimido derivative of NODAGA

Direct comparison of In-111-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging

Rosik, Daniel; Orlova, Anna; Malmberg, Jennie; Altai, Mohamed et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 693-702, 2012

• DOI för Direct comparison of In-111-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging

Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell line

Barta, Pavel; Malmberg, Jennie; Melicharova, Ludmila; Strandgård, John et al.

Ingår i International Journal of Oncology, s. 1677-1682, 2012

• DOI för Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell line

Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design

Hosseinimehr, Seyed Jalal; Tolmachev, Vladimir; Orlova, Anna

Ingår i Drug Discovery Today, s. 1224-1232, 2012

• DOI för Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design

Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule ¹¹¹In-DOTA-Z_IGF1R:4551

Tolmachev, Vladimir; Malmberg, Jennie; Hofström, Camilla; Abrahmsén, Lars et al.

Ingår i Journal of Nuclear Medicine, s. 90-97, 2012

• DOI för Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule ¹¹¹In-DOTA-Z_IGF1R:4551

99mTc(CO)3-HEHEHE-ZIGF1R:4551 affibody molecule, a poteintial imaging agent for visualization of insulin-like growth factor-1 receptor in malignant tumors

Tolmachev, Vladimir; Hofstrom, C.; Strand, J.; Varasteh, Zohreh et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2012

Comparative evaluation of anti-HER2 affibody molecules labeled with 68Ga and 111In using maleimido derivatives of DOTA and NODAGA

Altai, Mohamed; Strand, Joanna; Rosik, D.; Selvaraju, Ram Kumar et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2012

Influence of DOTA chelator position on biodistribution and targeting properties of 111 In-labelled anti-HER2 affibody molecules

Honarvar, Hadis; Perols, A.; Strand, Joanna; Selvaraju, Ram Kumar et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2012

Development of 124I-labelled anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer

Malmberg, Jennie; Selvaraju, Ram Kumar; Tolmachev, Vladimir; Orlova, Anna

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2012

Site-specific radioiodination of HER2-targeting affibody molecules using iodophenetylmaleimide decreases renal uptake of radioactivity

Strand, Joanna; Nordeman, Patrik; Honarvar, Hadis; Altai, Mohamed et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2012

Synthesis and characterization of a high affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging

Varasteh, Zohreh; Velikyan, Irina; Lindeberg, Gunnar; Sörensen, Jens et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2012

Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of In-111-Labeled Synthetic Anti-HER2 Affibody Molecules

Perols, Anna; Honarvar, Hadis; Strand, Joanna; Selvaraju, Ramkumar et al.

Ingår i Bioconjugate chemistry, s. 1661-1670, 2012

• DOI för Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of In-111-Labeled Synthetic Anti-HER2 Affibody Molecules

Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition

Tolmachev, Vladimir; Tran, Thuy A; Rosik, Daniel; Sjöberg, Anna et al.

Ingår i Journal of Nuclear Medicine, s. 953-960, 2012

• DOI för Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition

Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for ^99mTc-labelling at the C terminus

Lindberg, Hanna; Hofström, Camilla; Altai, Mohamed; Honorvar, Hadis et al.

Ingår i Tumor Biology, s. 641-651, 2012

• DOI för Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for ^99mTc-labelling at the C terminus

Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of (99m)Tc-labeled recombinant Affibody molecules

Altai, Mohamed; Wållberg, Helena; Orlova, Anna; Rosestedt, Maria et al.

Ingår i Amino Acids, s. 1975-1985, 2012

• DOI för Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of (99m)Tc-labeled recombinant Affibody molecules

Influence of an aliphatic linker between DOTA and synthetic Z(HER2:342) Affibody molecule on targeting properties of the (111)In-labeled conjugate

Tolmachev, Vladimir; Feldwisch, Joachim; Lindborg, Malin; Baastrup, Barbro et al.

Ingår i Nuclear Medicine and Biology, s. 697-706, 2011

• DOI för Influence of an aliphatic linker between DOTA and synthetic Z(HER2:342) Affibody molecule on targeting properties of the (111)In-labeled conjugate

Engineering of C-terminal cysteine-containing peptide-based chelators improves biodistribution of HER2-targeting ^99mTc-labeled Affibody molecules

Wållberg, H; Orlova, Anna; Altai, Mohammed; Hosseinimehr, Seyed Jalal et al.

Ingår i Journal of Nuclear Medicine, s. 461-469, 2011

• DOI för Engineering of C-terminal cysteine-containing peptide-based chelators improves biodistribution of HER2-targeting ^99mTc-labeled Affibody molecules

Use of a HEHEHE Purification Tag Instead of a Hexahistidine Tag Improves Biodistribution of Affibody Molecules Site-Specifically Labeled with Tc-99m, In-111 and I-125

Hofström, Camilla; Orlova, Anna; Altai, Mohamed; Wångsell, Fredrik et al.

Ingår i Journal of Medicinal Chemistry, s. 3817-3826, 2011

• DOI för Use of a HEHEHE Purification Tag Instead of a Hexahistidine Tag Improves Biodistribution of Affibody Molecules Site-Specifically Labeled with Tc-99m, In-111 and I-125

Imaging agents for in vivo molecular profiling of disseminated prostate cancer - targeting EGFR receptors in prostate cancer: Comparison of cellular processing of [In-111]-labeled affibody molecule Z(EGFR:2377) and cetuximab

Malmberg, Jennie; Tolmachev, Vladimir; Orlova, Anna

Ingår i International Journal of Oncology, s. 1137-1143, 2011

• DOI för Imaging agents for in vivo molecular profiling of disseminated prostate cancer - targeting EGFR receptors in prostate cancer: Comparison of cellular processing of [In-111]-labeled affibody molecule Z(EGFR:2377) and cetuximab

Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels

Tolmachev, Vladimir; Wållberg, Helena; Sandström, Mattias; Hansson, Monika et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 531-539, 2011

• DOI för Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels

Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties

Wållberg, Helena; Orlova, Anna; Altai, Mohammed; Hosseinimehr, Seyed Jalal et al.

Ingår i Journal of Nuclear Medicine, s. 461-469, 2011

• DOI för Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties

Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [In-111]-labeled CHX-A "DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines

Malmberg, Jennie; Tolmachev, Vladimir; Orlova, Anna

Ingår i Experimental and Therapeutic Medicine, s. 523-528, 2011

• DOI för Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [In-111]-labeled CHX-A "DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines

Evaluation of a Maleimido Derivative of NOTA for Site-Specific Labeling of Affibody Molecules

Tolmachev, Vladimir; Altai, Mohamed; Sandström, Mattias; Perols, Anna et al.

Ingår i Bioconjugate chemistry, s. 894-902, 2011

• DOI för Evaluation of a Maleimido Derivative of NOTA for Site-Specific Labeling of Affibody Molecules

Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on (111)In- and (125)I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 Affibody

Malmberg, Jennie; Sandström, Mattias; Wester, Kenneth; Tolmachev, Vladimir et al.

Ingår i Nuclear Medicine and Biology, s. 1093-1102, 2011

• DOI för Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on (111)In- and (125)I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 Affibody

Targeting of HER2-Expressing Tumors Using ¹¹¹In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold

Ahlgren, Sara; Orlova, Anna; Wållberg, Helena; Hansson, Monika et al.

Ingår i Journal of Nuclear Medicine, s. 1131-1138, 2010

• DOI för Targeting of HER2-Expressing Tumors Using ¹¹¹In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold

Evaluation of the Radiocobalt-Labeled [MMA-DOTA-Cys⁶¹]-Z_HER2:2395-Cys Affibody Molecule for Targeting of HER2-Expressing Tumors

Wållberg, Helena; Ahlgren, Sara; Widström, Charles; Orlova, Anna

Ingår i Molecular Imaging and Biology, s. 54-62, 2010

• DOI för Evaluation of the Radiocobalt-Labeled [MMA-DOTA-Cys⁶¹]-Z_HER2:2395-Cys Affibody Molecule for Targeting of HER2-Expressing Tumors

HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [Tc-99m(CO)(3)](+), and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation

Tolmachev, Vladimir; Hofström, Camilla; Malmberg, Jennie; Ahlgren, Sara et al.

Ingår i Bioconjugate chemistry, s. 2013-2022, 2010

• DOI för HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [Tc-99m(CO)(3)](+), and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation

Influence of an aliphatic linker between DOTA and synthetic Affibody molecule on targeting properties

Orlova, Anna; Feldwisch, Joachim; Tolmachev, Vladimir

Ingår i Nuclear Medicine and Biology, s. 695-695, 2010

• DOI för Influence of an aliphatic linker between DOTA and synthetic Affibody molecule on targeting properties

HER2 targeting with Tc-99m-labeled second generation synthetic Affibody molecule

Tolmachev, Vladimir; Wallberg, Helena; Feldwisch, Joachim; Orlova, Anna

Ingår i Nuclear Medicine and Biology, s. 705-706, 2010

• DOI för HER2 targeting with Tc-99m-labeled second generation synthetic Affibody molecule

HEHEHE: a new chelator for [Tc-99m(CO)(3)](+)-labeling assembling His(6)-tag in protein purification

Tolmachev, Vladimir; Hofström, Camilla; Malmberg, Jennie; Ahlgren, Sara et al.

Ingår i Nuclear Medicine and Biology, s. 698-698, 2010

• DOI för HEHEHE: a new chelator for [Tc-99m(CO)(3)](+)-labeling assembling His(6)-tag in protein purification

Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules

Baum, Richard P; Prasad, Vikas; Müller, Dirk; Schuchardt, Christiane et al.

Ingår i Journal of Nuclear Medicine, s. 892-897, 2010

• DOI för Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules

Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets

Tolmachev, Vladimir; Orlova, Anna

Ingår i Current Medicinal Chemistry, s. 2636-2655, 2010

• DOI för Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets

Re-186-maSGS-Z(HER2:342), a potential Affibody conjugate for systemic therapy of HER2-expressing tumours

Orlova, Anna; Tran, Thuy A; Ekblad, Torun; Karlström, Amelie Eriksson et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 260-269, 2010

• DOI för Re-186-maSGS-Z(HER2:342), a potential Affibody conjugate for systemic therapy of HER2-expressing tumours

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR In-111-DOTA-Z(EGFR:2377) Affibody molecule: aspect of the injected tracer amount

Tolmachev, Vladimir; Rosik, Daniel; Wållberg, Helena; Sjöberg, Anna et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 613-622, 2010

• DOI för Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR In-111-DOTA-Z(EGFR:2377) Affibody molecule: aspect of the injected tracer amount

A HER2-binding Affibody molecule labelled with ⁶⁸Ga for PET imaging: direct in vivo comparison with the ¹¹¹In-labelled analogue

Tolmachev, Vladimir; Velikyan, Irina; Sandström, Mattias; Orlova, Anna

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 1356-1367, 2010

• DOI för A HER2-binding Affibody molecule labelled with ⁶⁸Ga for PET imaging: direct in vivo comparison with the ¹¹¹In-labelled analogue

Quantification of internalization of EGFR-binding Affibody molecules: Methodological aspects

Göstring, Lovisa; Chew, Ming Tsuey; Orlova, Anna; Höidén-Guthenberg, Ingmarie et al.

Ingår i International Journal of Oncology, s. 757-763, 2010

• DOI för Quantification of internalization of EGFR-binding Affibody molecules: Methodological aspects

Preparation and in vitro evaluation of 111In-CHX-A"-DTPA-labeled anti-VEGF monoclonal antibody bevacizumab.

Hosseinimehr, Seyed Jalal; Orlova, Anna; Tolmachev, Vladimir

Ingår i Human antibodies, s. 107-11, 2010

• DOI för Preparation and in vitro evaluation of 111In-CHX-A"-DTPA-labeled anti-VEGF monoclonal antibody bevacizumab.

Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imaging

Tran, Thuy A.; Rosik, Daniel; Abrahmsén, Lars; Sandström, Mattias et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 1864-1873, 2009

• DOI för Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imaging

Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine

Ahlgren, Sara; Wållberg, Helena; Tran, Thuy A.; Widström, Charles et al.

Ingår i Journal of Nuclear Medicine, s. 781-789, 2009

• DOI för Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine

The influence of Bz-DOTA and CHX-AaEuro(3)-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for In-114m-mediated targeting therapy

Tolmachev, Vladimir; Wallberg, Helena; Andersson, Karl; Wennborg, Anders et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 1460-1468, 2009

• DOI för The influence of Bz-DOTA and CHX-AaEuro(3)-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for In-114m-mediated targeting therapy

Synthesis and chemoselective intramolecular cross-linking of a HER2-binding Affibody

Ekblad, Torun; Tolmachev, Vladimir; Orlova, Anna; Lendel, Christofer et al.

Ingår i Biopolymers, s. 116-123, 2009

• DOI för Synthesis and chemoselective intramolecular cross-linking of a HER2-binding Affibody

On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of ¹²⁴I-labelled Affibody molecule and trastuzumab in a murine xenograft model

Orlova, Anna; Wållberg, Helena; Stone-Elander, Sharon; Tolmachev, Vladimir

Ingår i European Journal of Nuclear Medicine, s. 417-425, 2009

• DOI för On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of ¹²⁴I-labelled Affibody molecule and trastuzumab in a murine xenograft model

Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry

Tolmachev, Vladimir; Friedman, Mikaela; Sandström, Mattias; Eriksson, Tove L. et al.

Ingår i Journal of Nuclear Medicine, s. 274-283, 2009

• DOI för Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry

Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding

Tolmachev, Vladimir; Mume, Eskender; Sjöberg, Stefan; Frejd, Fredrik Y. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 692-701, 2009

• DOI för Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding

Positioning of Tc-99m-chelators influences radiolabeling, stability and biodistribution of Affibody molecules

Ekblad, Torun; Orlova, Anna; Feldwisch, Joachim; Wennborg, Anders et al.

Ingår i Bioorganic & Medicinal Chemistry Letters, s. 3912-3914, 2009

• DOI för Positioning of Tc-99m-chelators influences radiolabeling, stability and biodistribution of Affibody molecules

Update on Affibody molecules for in vivo imaging of targets for cancer therapy

Tolmachev, V; Orlova, A

Ingår i Minerva biotecnologica (Testo stampato), s. 21-30, 2009

Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of ^99mTc-labeled anti-HER2 Affibody molecules

Tran, Thuy; Ekblad, Torun; Orlova, Anna; Sandström, Mattias et al.

Ingår i Bioconjugate chemistry, s. 2568-2576, 2008

• DOI för Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of ^99mTc-labeled anti-HER2 Affibody molecules

In vivo and in vitro uptake of In-111, delivered with the affibody molecule(Z(EGFR:955))(2), in EGFR expressing tumour cells

Nordberg, Erika; Orlova, Anna; Friedman, M.; Tolmachev, Vladimir et al.

Ingår i Oncology Reports, s. 853-857, 2008

Targeting EGFR and HER2 with 211At-labeled molecules: unexpected and expected dose-effect relations in cultured tumor cells

Carlsson, Jörgen; Steffen, Ann-Charlott; Sundberg, Åsa L.; Vikström, Mikael et al.

Ingår i Current radiopharmaceuticals, s. 225-233, 2008

Slow internalization of anti-HER2 synthetic affibody monomer 111In-DOTA-ZHER2:342-pep2: implications for development of labeled tracers

Wållberg, Helena; Orlova, Anna

Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 435-442, 2008

• DOI för Slow internalization of anti-HER2 synthetic affibody monomer 111In-DOTA-ZHER2:342-pep2: implications for development of labeled tracers

Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules

Ahlgren, Sara; Orlova, Anna; Rosik, Daniel; Sandström, Mattias et al.

Ingår i Bioconjugate chemistry, s. 235-243, 2008

• DOI för Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules

Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules

Tolmachev, Vladimir; Xu, Heng; Wållberg, Helena; Ahlgren, Sara et al.

Ingår i Bioconjugate chemistry, s. 1579-1587, 2008

• DOI för Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules

Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake

Ekblad, Torun; Tran, Thuy; Orlova, Anna; Widström, Charles et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 2245-2255, 2008

• DOI för Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake

Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule

Friedman, Mikaela; Orlova, Anna; Johansson, Eva; Eriksson, Tove L. J. et al.

Ingår i Journal of Molecular Biology, s. 1388-1402, 2008

• DOI för Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule

Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence

Engfeldt, Torun; Orlova, Anna; Tran, Thuy; Bruskin, Alexander et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 722-733, 2007

• DOI för Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence

In Vivo Evaluation of Cysteine-Based Chelators for Attachment of 99mTc  to Tumor-Targeting Affibody Molecules

Thuy, Tran; Engfeldt, Torun; Orlova, Anna; Widström, Charles et al.

Ingår i Bioconjugate chemistry, s. 549-558, 2007

• DOI för In Vivo Evaluation of Cysteine-Based Chelators for Attachment of 99mTc  to Tumor-Targeting Affibody Molecules
• Ladda ner fulltext (pdf) av In Vivo Evaluation of Cysteine-Based Chelators for Attachment of 99mTc  to Tumor-Targeting Affibody Molecules

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule

Tolmachev, Vladimir; Orlova, Anna; Pehrson, Rikard; Galli, Joakim et al.

Ingår i Cancer Research, s. 2773-2782, 2007

• DOI för Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule

Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2:342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma

Fortin, Marc-André; Orlova, Anna; Malmström, Per-Uno; Tolmachev, Vladimir

Ingår i International Journal of Molecular Medicine, s. 285-291, 2007

Update: Affibody molecules for molecular imaging and therapy for cancer

Orlova, Anna; Feldwisch, Joachim; Abrahmsén, Lars; Tolmachev, Vladimir

Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 573-584, 2007

• DOI för Update: Affibody molecules for molecular imaging and therapy for cancer

Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors

Orlova, Anna; Rosik, Daniel; Sandström, Mattias; Lundqvist, Hans et al.

Ingår i The Quarterly Journal of Nuclear Medicine and Molecular Imaging, s. 314-323, 2007

Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors

Orlova, Anna; Tran, Thuy; Widström, Charles; Engfeldt, Torun et al.

Ingår i International Journal of Molecular Medicine, s. 397-404, 2007

(99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors

Tran, Thuy; Engfeldt, Torun; Orlova, Anna; Sandström, Mattias et al.

Ingår i Bioconjugate chemistry, s. 1956-1964, 2007

• DOI för (99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors

^99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule

Engfeldt, Torun; Tran, Thuy; Orlova, Anna; Widström, Charles et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 1843-1853, 2007

• DOI för ^99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

Orlova, Anna; Tolmachev, Vladimir; Pehrson, Rikard; Lindborg, Malin et al.

Ingår i Cancer Research, s. 2178-2186, 2007

• DOI för Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

Comparison of benzoate- and dodecaborate-based linkers for attachment of radioiodine to HER2-targeting Affibody ligand

Tran, Thuy; Orlova, Anna; Sivaev, Igor; Sandström, Mattias et al.

Ingår i International Journal of Molecular Medicine, s. 485-493, 2007

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors

Tolmachev, Vladimir; Nilsson, Fredrik Y.; Widström, Charles; Andersson, Karl et al.

Ingår i Journal of Nuclear Medicine, s. 846-53, 2006

Cellular processing in the SW1222 cell line of mAb A33 directly and indirectly radiohalogenated

Höglund, Johanna; Orlova, Anna; Sundin, Anders; Lundqvist, Hans et al.

Ingår i Oncology Reports, s. 159-63, 2006

Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI)

Orlova, Anna; Bruskin, Alexander; Sivaev, Igor; Sjöberg, Stefan et al.

Ingår i Anticancer Research, s. 1217-23, 2006

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

Orlova, Anna; Magnusson, Mikaela; Eriksson, Tove L. J.; Nilsson, Martin et al.

Ingår i Cancer Research, s. 4339-48, 2006

• DOI för Tumor imaging using a picomolar affinity HER2 binding affibody molecule

Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice

Steffen, Ann-Charlott; Orlova, Anna; Wikman, Maria; Nilsson, Fredrik Y. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 631-638, 2006

• DOI för Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice

Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors

Orlova, Anna; Nilsson, Fredrik Y.; Wikman, Maria; Widström, Charles et al.

Ingår i Journal of Nuclear Medicine, s. 512-519, 2006

An aminoacridine derivative for radionuclide therapy: DNA binding properties studied in a novel cell-free in vitro assay

Kullberg, Erika Bohl; Stenerlöw, Bo; Ghirmai, Senait; Lundqvist, Hans et al.

Ingår i International Journal of Oncology, s. 1355-60, 2005

An Aminoacridine Derivative for Radionuclide Therapy: Dna-Binding Properties Studied in a Novel Cell-Free in vitro Assay

Kullberg, E-B.; Stenerlöw, B.; Ghirmait, Senait; Lundqvist, Hans et al.

Ingår i Int. J. Onc., s. 1355-1360, 2005

Evaluation of ((4-Hydroxyphenyl)ethyl)maleimide for Site-Specific Radiobromination of Anti-HER2 Affibody

Mume, Eskender; Orlova, Anna; Larsson, Barbro; Nilsson, Ann-Sofie et al.

Ingår i Bioconjugate chemistry, s. 1547-1555, 2005

• DOI för Evaluation of ((4-Hydroxyphenyl)ethyl)maleimide for Site-Specific Radiobromination of Anti-HER2 Affibody

[99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: preparation and pre-clinical evaluation

Babaei, Mohammad Hossein; Almqvist, Ylva; Orlova, Anna; Shafii, Mohammad et al.

Ingår i Oncology Reports, s. 1169-75, 2005

In vitro characterization of 211 At-labeled antibody A33: a potential therapeutic agent against metastatic colorectal carcinoma

Almqvist, Ylva; Orlova, Anna; Sjöström, Anna; Jensen, Holger J. et al.

Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 514-523, 2005

• DOI för In vitro characterization of 211 At-labeled antibody A33: a potential therapeutic agent against metastatic colorectal carcinoma

Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET

Mume, Eskender; Orlova, Anna; Malmström, Per-Uno; Lundqvist, Hans et al.

Ingår i Nuclear Medicine and Biology, s. 613-22, 2005

• DOI för Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET

Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice

Tolmachev, Vladimir; Orlova, Anna; Wei, Qichun; Bruskin, Alexander et al.

Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 491-501, 2004

• DOI för Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice

[177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma

Sundberg, Åsa Liljegren; Gedda, Lars; Orlova, Anna; Bruskin, Alexander et al.

Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 195-204, 2004

• DOI för [177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma

Targeting against epidermal growth factor receptors: Cellular processing of astatinated EGF after binding to cultured carcinoma cells

Orlova, Anna; Sjöström, Anna; Lebeda, Ondrej; Lundqvist, Hans et al.

Ingår i Anticancer Research, s. 4035-4042, 2004

Targeting of a head and neck squamous cell carcinoma xenograft model using the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker

Cheng, Junping; Persson, Mikael; Tolmachev, Vladimir; Siavaev, Igor et al.

Ingår i Acta Oto-Laryngologica, s. 1078-85, 2004

Copper-mediated isotopic exchange between [125I]iodide and bis(triethylammonium) undecahydro-12-iodo-closo-dodecaborate in aqueous media

Schukin, E.; Orlova, Anna; Korsakov, M.; Sjöberg, Stefan et al.

Ingår i Journal of Radioanalytical and Nuclear Chemistry, s. 295-299, 2004

• DOI för Copper-mediated isotopic exchange between [125I]iodide and bis(triethylammonium) undecahydro-12-iodo-closo-dodecaborate in aqueous media

Synthesis and Radioiodination of Some 9-Aminoacridine Derivatives

Ghirmai, Senait; Mume, Eskender; Henssen, Cecile; Ghaneolhusseini, Hadi et al.

Ingår i European Journal of Organic Chemistry, s. 3719-3725, 2004

• DOI för Synthesis and Radioiodination of Some 9-Aminoacridine Derivatives

Radioiodination of ammonio-closo-monocarborane, 1-H3N-1-CB1 H11: Aspects of labelling chemistry in aqueous solution using Chloramine-T

Orlova, Anna; Sivaev, I.; Sjöberg, Stefan; Lundqvist, Hans et al.

Ingår i Radiochimica Acta, s. 311, 2004

Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF

Sundberg, Åsa Liljegren; Almqvist, Ylva; Orlova, Anna; Blomquist, Erik et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 1348-56, 2003

• DOI för Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF

[111In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent

Sundberg, Åsa Liljegren; Orlova, Anna; Bruskin, Alexander; Gedda, Lars et al.

Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 643-54, 2003

• DOI för [111In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent

Feasibility of isotopic exchange in system [125I] iodide – undecahydro-iodo-closo-dodecaborate (2-) anion

Korsakov, M. V.; Shchukin, E. V.; Korsakova, L. N.; Orlova, Anna M. et al.

Ingår i Journal of Radioanalytical and Nuclear Chemistry, s. 67-71, 2003

Approaches to improve cellular retention of radiohalogen labels delivered by internalising tumour-targeting proteins and peptides

Tolmachev, Vladimir; Orlova, Anna; Lundqvist, Hans

Ingår i Current Medicinal Chemistry, s. 2447-60, 2003

Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33: Implications for in vivo dosimetry

Orlova, Anna; Höglund, Johanna; Lubberink, Mark; Lebeda, Ondrej et al.

Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 385-96, 2002

• DOI för Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33: Implications for in vivo dosimetry

Preparation of [76Br] 5-bromo-2-thiouracil, a positron-emitting melanoma loclizing agent

Tolmachev, Vladimir; Orlova, Anna; Sundin, A

Ingår i Journal of Radioanalytical and Nuclear Chemistry, s. 409-441, 2002

Cellular processing of (125)I- and (111)in-labeled epidermal growth factor(EGF) bound to cultured A431 tumor cells

Orlova, Anna; Bruskin, Alexander; Sjöström, Anna; Lundqvist, Hans et al.

Ingår i Nuclear Medicine and Biology, s. 827-35, 2000

• DOI för Cellular processing of (125)I- and (111)in-labeled epidermal growth factor(EGF) bound to cultured A431 tumor cells

Optimized indirect (76)Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PET

Höglund, Johanna; Tolmachev, Vladimir; Orlova, Anna; Lundqvist, Hans et al.

Ingår i Nuclear Medicine and Biology, s. 837-43, 2000

• DOI för Optimized indirect (76)Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PET

Optimization of iodination of [125I]-N-succinimidyl-para-iodobenzoate using Chloromine-T for labeling of proteins

Tolmachev, Vladimir; Orlova, Anna; Lundqvist, Hans

Ingår i Journal of Radioanalytical and Nuclear Chemistry, s. 207-213, 2000

Closo-dodecaborate(2-)anion as a potential prosthetic group for attachment of astatine to proteins: Aspects of the labelling chemistry with Chloramine -T

Orlova, Anna; Lebeda, Ondrej; Tolmachev, Vladimir; Sjöberg, Stefan et al.

Ingår i Journal of labelled compounds & radiopharmaceuticals, s. 251-260, 2000

Closo-dodecaborate(2-) as a linker for iodination of macromolecules: Aspects on conjugation chemistry and biodistribution

Tolmachev, Vladimir; Koziorowski, Jacek; Sivaev, Igor; Lundqvist, Hans et al.

Ingår i Bioconjugate chemistry, s. 338-45, 1999

• DOI för Closo-dodecaborate(2-) as a linker for iodination of macromolecules: Aspects on conjugation chemistry and biodistribution

Labelling of boron containing compounds with halogen isotopes

Tolmachev, Vladimir; Lundqvist, Hans; Sivaev, Igor; Orlova, Anna et al.

Ingår i Journal of labelled compounds & radiopharmaceuticals, s. 122, 1997

Labelling and in vivo evaluation of closo-dodecaborate as a linker for attachment of iodine to radiopharma-ceuticals

Tolmachev, Vladimir; Lundqvist, Hans; Carlsson, Jörgen; Sivaev, Igor et al.

Ingår i Journal of labelled compounds & radiopharmaceuticals, s. 125-127, 1997

• DOI för Labelling and in vivo evaluation of closo-dodecaborate as a linker for attachment of iodine to radiopharma-ceuticals

The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer

Li, Mei; Zelchan, Roman; Orlova, Anna

Ingår i Biomedicines, 2022

• DOI för The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer
• Ladda ner fulltext (pdf) av The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer

PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology

Rinne, Sara S.; Orlova, Anna; Tolmachev, Vladimir

Ingår i International Journal of Molecular Sciences, 2021

• DOI för PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
• Ladda ner fulltext (pdf) av PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology

The emerging role of radionuclide molecular imaging of HER2 expression in breast cancer

Tolmachev, Vladimir; Orlova, Anna; Sörensen, Jens

Ingår i Seminars in Cancer Biology, s. 185-197, 2021

• DOI för The emerging role of radionuclide molecular imaging of HER2 expression in breast cancer

Affibody Molecules as Targeting Vectors for PET Imaging

Tolmachev, Vladimir; Orlova, Anna

Ingår i Cancers, 2020

• DOI för Affibody Molecules as Targeting Vectors for PET Imaging
• Ladda ner fulltext (pdf) av Affibody Molecules as Targeting Vectors for PET Imaging

Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer: Influence of Labeling Chemistry on Targeting Properties

Mitran, Bogdan; Tolmachev, Vladimir; Orlova, Anna

Ingår i Current Medicinal Chemistry, s. 7090-7111, 2020

• DOI för Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer: Influence of Labeling Chemistry on Targeting Properties

Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls

Tolmachev, Vladimir; Stone-Elander, Sharon; Orlova, Anna

Ingår i The Lancet Oncology, s. 992-1000, 2010

• DOI för Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy

Tolmachev, Vladimir; Orlova, Anna; Nilsson, Fredrik Y.; Feldwisch, Joachim et al.

Ingår i Expert Opinion on Biological Therapy, s. 555-568, 2007

• DOI för Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy

Methods for radiolabelling of monoclonal antibodies

Tolmachev, Vladimir; Orlova, Anna; Andersson, Karl

Ingår i Human Monoclonal Antibodies, s. 309-330, Humana Press, 2014

• DOI för Methods for radiolabelling of monoclonal antibodies
• Ladda ner fulltext (pdf) av Methods for radiolabelling of monoclonal antibodies

Radiohalogenated Polyhedral Borate Anaions for use in Targeted Oncological Radionuclide Therapy, Some Recent Developments

Tolmachev, V.; Bruskin, A.; Orlova, A.; Winberg, K.J. et al.

Ingår i Boron Chemistry at the Beginning of the 21st Century. Y.N Bubnov, s. 338-3342, Editoral URSS, Scientific Literature and Textbooks,, Moscow, 2003

Effect of ionizing radiation on the labeling of closo-dodecaborate(2-) anion with 125I

Lebeda, Ondrej; Orlova, Anna; Tolmachev, Vladimir; Lundqvist, Hans et al.

Ingår i Contemporary Boron Chemistry, Royal Society of Medicine Press, 2000

• DOI för Effect of ionizing radiation on the labeling of closo-dodecaborate(2-) anion with 125I

Effect of ionising radiation on the labelling of closo-dodecaborate (2-) anion

Lebeda, Ondrej; Orlova, Anna; Tolmachev, Vladimir; Lundqvist, Hans et al.

Ingår i Contemporary Boron Chemistry, s. 148-154, Royal Society of Chemistry, 2000

Closo-dodecaborate (2-) anion as a prosthetic group for labelling proteins with a astatine

Orlova, Anna; Lebeda, O.; Tolmachev, Vladimir; Sjöberg, S. et al.

Ingår i Contemporary Boron Chemistry, s. 144-147, Royal Society of Chemistry, 2000

Polyhedral boron clasters as linkers for attachment of radiohalogens to tumor targeting proteins. II. Radioiodination of monoclonal antibody using potassium [125I]-4-(isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (Iodo-DABI)

Orlova, Anna; Bruskin, Alexander; Sivaev, Igor; Sjoberg, Stefan et al.

Pharmacokinetics in tumour-bearing rats of directly and indirectly ⁷⁶Br-brominated MAb A33: Comparison with ¹²⁵I-iodinated counterparts

Höglund, Johanna; Tolmachev, Vladimir; Orlova, Anna; Lundqvist, Hans et al.

Synthesis and Preclinical Evaluation of GRPR Antagonist [¹⁸F]-MeTz-PEG₂-RM26 for Position Emission Tomography

Lundmark, Fanny; Abouzayed, Ayman; Kanellopoulos, Panagiotis; Tolmachev, Vladimir et al.

Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI)

Orlova, Anna; Bruskin, Alexander; Sivaev, Igor; Sjöberg, Stefan et al.

Ingår i Anticancer Research, s. 1217-1223, 2006

Cellular processing of iodinated and astatinated trastuzumab in cultured SK-BR-3 breast cancer cells

Persson, Mikael; Orlova, Anna; Gedda, Lars; Carlsson, Jörgen et al.

Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 353-354, 2002

[111In]-DTPA-hEGF and [111In]-Bz-DTPA-hEGF: preparation and in vitro studies of two anti- glioblastoma conjugates with residualising labels

Liljegren Sundberg, Åsa; Orlova, Anna; Bruskin, Alexander; Gedda, Lars et al.

Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 354-354, 2002

[111In] benzyl-DTPA-EGF, a new potential radiopeptide for targeting of glioma

Orlova, Anna; Sundberg, Å.; Bruskin, Alexander; Gedda, Lars et al.

Ingår i European Journal of Nuclear Medicine, 2002

The use of benzyl isothiocyanate derivative of closo-dodecaborate dianion for indirect radioiodination and radiobromination of monoclonal antibodies

Tolmachev, Vladimir; Orlova, Anna; Bruskin, Alexander; Sivaev, Igor et al.

Ingår i European Journal of Nuclear Medicine, 2002

Pharmacokinetics in tumour-bearing rats of directly and indirectly 76Br-brominated MAb A33: Comparison with 125I-iodinated counterparts

Höglund, Johanna; Orlova, Anna; Tolmachev, Vladimir; Lundqvist, Hans et al.

2002

Cellular processing of indirectly astatinated and iodinated mAb A33 in SW1222 cultured cells

Orlova, Anna; Sjöström, Anna; Ericson, A.; Lebeda, Ondrej et al.

Ingår i Journal of labelled compounds & radiopharmaceuticals, 2001

• DOI för Cellular processing of indirectly astatinated and iodinated mAb A33 in SW1222 cultured cells

Synthesis of [211At] N-[8-(acridin-9-ylamino)-octyl]-3- astatobenzamide, an astatinated DNA intercalator

Orlova, Anna; Bohl, E.; Ghaneolhosseino, H.; Gedda, Lars et al.

Ingår i European Journal of Nuclear Medicine, s. 317, 2000

Cellular processing of ¹²⁵I- and ¹¹¹in-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells

Orlova, Anna; Bruskin, Alexander; Sjöström, Anna; Lundqvist, Hans et al.

Ingår i Nuclear Medicine and Biology, s. 827-835, 2000

• DOI för Cellular processing of ¹²⁵I- and ¹¹¹in-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells

Intercalators labelled with Auger emitting nuclides

Lundqvist, Hans; Stenerlöw, Bo; Tolmachev, Vladimir; Orlova, Anna et al.

1999